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ABSTRACT 
Swelling  in  thyroid  are frequently  encountered  .  Clinical evaluation  helps  
in diagnosis but is difficult to distinguish the early malignant lesions from the 
more prevalent benign goiters. FNAC is a simple and safe procedure , carried 
out in OPD with minimum equipment  and has good patient compliance . As 
FNAC is the primary investigation for the management of thyroid lesions , its 
interpretation is very crucial . This study aims at classifying the 
cytomorpholgical profile of  nodular and diffuse thyromegaly cases with 
emphasis on Bethesda system of reporting. The Bethesda System for Reporting 
Thyroid Cytopathology ( TBSRTC)  is used for clarity of communication and 
recommends  that each case should be reported in 1 of 6 diagnostic categories 
which include Category I –Non –diagnostic , Category II- Benign, Category III-
Atypia of undetermined significance/ Follicular lesion of undetermined 
significance (AUS/FLUS) ,Category IV- Follicular neoplasm / Suspicious for 
follicular neoplasm  (FN/SFN), Category V- Suspicious for malignancy (SFM),  
CategoryVI – Malignant, thus facilitating a uniform communication among the 
managing team of doctors and leaves no  confusion regarding the management 
of thyroid lesions.  
                       A total of 300 cases with   thyroid  swellings were studied during 
the period of January 2013 to June 2014 . FNAC of thyroid was done in all 
cases  and the cytomorpholgy of the individual thyroid lesions were evaluated 
and all cases were reported using TBSRTC. Of the total 300 cases , 3 cases(1%) 
were reported in category I , 274 cases (91.3%) were reported in category II   , 1 
case(0.3%)  in category III , 12 case ( 4%) in category IV , 2 cases (0.7%) in 
category V, 8 cases (2.7%) in category VI. Major bulk of cases were seen in 
category II. 
             Thus the  application of   TBSRTC  bridges the gap in communication 
between the clincians   and helps in the proper patient management . 
Keywords : FNAC, thyroid lesions , Bethesda 
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INTRODUCTION 
Thyroid lesions are one of the common clinical conditions being 
encountered in clinical practice and are different from other diseases in terms 
of their ease of diagnosis, accessibility of medical treatment, and the relative 
visibility of the swelling that even a small swelling of the thyroid offers to 
the treating physician. Early diagnosis and treatment remains the cornerstone 
of management. 
The annual incidence of thyroid malignancy ranges from 0.5 to 10 
cases per 1,00,000 population.
[1]
 With a wide spectrum of disorders and a 
considerable degree of variation in its presentation, it is often difficult to 
arrive at a correct diagnosis by clinical evaluation alone. So it is essential to 
have a battery of test done which include: thyroid hormonal profile, 
ultrasound imaging studies and Fine Needle Aspiration Cytology. 
Fine Needle Aspiration Cytology is an outpatient procedure which is 
used as a primary investigation in the diagnosis of thyroid swellings. It is a 
simple, speedy, safe, cost effective and accurate technique being used 
worldwide for evaluation of thyroid swellings. The clinical value of thyroid 
FNAC is useful in the diagnosis of inflammatory, infectious and neoplastic 
conditions.
[2] 
  As FNAC defines the difference between the benign and cancerous 
lesions very accurately therefore it is used as a best screening tool in the 
preoperative diagnosis throught the world. 
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  The thyroid nodules have a reported prevalence of 4 to 7% in the 
general population.
[3-6] 
Thyroid cancer is the most common type of endocrine 
malignancy. It constitutes 1.7% of all newly diagnosed cancer cases 
worldwide. The incidence of thyroid cancer is about three times higher 
among females than males.
[7] 
The incidence of thyroid cancer is rare in children, but its incidence 
begins to rise sharply in the second decade of life and peaks during the fifth 
and sixth decades of life. Papillary carcinoma of thyroid constitutes ~ 80% of 
all thyroid cancer cases, follicular carcinoma (15%), and medullary 
carcinoma (3%). Anaplastic carcinoma which accounts for < 2% of thyroid 
tumors, typically occurs in the older age group and its incidence continues to 
rise with age
.[7] 
This study aims at classifying the cytomorphological profile of 
nodular and diffuse lesions of thyroid under the standardized Bethesda 
system of reporting thereby establishing its role in proper diagnosis and 
maintaining a uniform communication among different clinicians to avoid 
confusion and thus helps in proper patient management. 
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AIMS AND OBJECTIVES 
A prospective study is carried out on fine needle aspiration cytology 
of thyroid lesions with the following objectives. 
1. To study the cytomorphological features of aspirated material from 
various thyroid lesions like nodular and diffuse thyromegaly. 
2. To correlate the cytomorpholgical features and classify the thyroid 
lesions with emphasis on Bethesda system of reporting. 
3. To study the utility of the Bethesda system of reporting 
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REVIEW OF LITERATURE 
EMBRYOLOGY 
The thyroid gland develops as an outpouching of the primitive foregut 
in early weeks of gestation at the site of foramen caecum in the base of the 
tongue. The endoderm cells which are seen lining the floor of pharyngeal 
anlage thicken and form the median thyroid anlage.The thyroid gland 
descends in the midline as a component of the thyroglossal duct to reach its 
final position in the mid neck. The second branchial arch forms the hyoid 
bone. The thyrogossal duct is situated anterior to the hyoid bone and is 
divided by the hyoid bone into a suprahyoid and an infrahyoid portion.In due 
course the thyroglossal duct is obliterated and leaves a vestige of pyramidal 
lobe in 40% of individuals. The paired lateral anlages originate from fourth 
branchial pouch and fuse with median anlage at fifth week of gestation.
[8]
  
The lateral anlages are neuroectodermal in origin (ultimobranchial 
bodies) and contain the parafollicular or C cells which produce calcitonin 
[9] 
The cords and plates of thyroid follicular cells are formed by the end of the 
9
th
 week, the small follicular lumen is formed by 10
th
 week, the colloid 
secretion occurs by 12
th
 week and thyroglobulin positive colloid in lumen by 
14
th
 week.
[10]
 
The development of the thyroid gland is controlled by specific 
transcription factors such as TTF-1, TTF-2,PAX8, HHEX and their altered 
expression plays a role in thyroid dysgenesis.
[11]
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ANATOMY  
Thyroid gland is placed in front of the neck, anterior to the trachea and 
composed of two lobes which are connected by isthmus. The two lobes of 
the thyroid are divided by fibrous septa into lobules, and each lobule 
contains about 30 to 40 follicles. The whole thyroid gland is enclosed in a 
true capsule. Mature thyroid gland measures about 6×3×2 cms 
approximately and weighs about 25-30 gms. Thyroid gland is a highly 
vascular structure and it is supplied by subclavian artey and carotid artery. 
There are four pea sized parathyroid glands embedded posteriorly in superior 
and inferior pole of thyroid gland.
[8]
  
HISTOLOGY 
The follicles in thyroid gland are round to oval with an average 
diameter of 200 µm lined by thyroid follicular cells.The follicles in thyroid 
are often filled with colloid which is described as a homogenous eosinophilic 
material. There are variations in the density and in the staining properties of 
the colloid according to the different clinical conditions. The prescence of 
thin eosinophilic colloid indicates that the gland is functionally active and 
the prescence of thick eosinophilic colloid appears to be associated with 
inactive follicles and is also seen in some malignant conditions of 
thyroid.The appearance of follicular cells depends on the functional activity 
of the thyroid gland. 
[8]
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PHYSIOLOGY 
The main function of thyroid gland is secretion of thyroid hormones 
and calcitonin. Regulation of thyroid function is by the hormone TSH which 
is secreted from the anterior pituitary.The lesions in thyroid are largely 
divided into two major types: the lesions that show a diffuse pattern and the 
lesions that are associated with nodular pattern. The nodules in turn can be 
divided into solitary or multiple. 
CLASSIFICATION OF THYROID SWELLING 
[12] 
1. SIMPLE GOITRE(EUTHYROID) 
Diffuse hyperplastic - (Physiological,Pubertal, Pregnancy) 
Multinodular goitre  
2. TOXIC 
Diffuse (Grave’s disease) 
Multinodular (Toxic adenoma) 
3. INFLAMMATORY 
Autoimmune -  Hashimoto’s thyroiditis 
  - Classic lymphocytic thyroiditis 
Granulomatous - De Quervain’s thyroiditis 
Fibrosing  - Riedel’s thyroiditis 
Infective - Acute (bacterial thyroiditis, viral thyroiditis,)       
          - Chronic (tuberculosis, syphilis) 
4. NEOPLASTIC  
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NON –NEOPLASTIC LESIONS OF THYROID  
DIFFUSE NON TOXIC (SIMPLE) GOITER OR COLLOID GOITER 
The other names of this goitre include adenomatous goiter, diffuse or 
nodular goiter, endemic goiter, multinodular goitre. This type of goitre is 
usually caused by hyperplasia of the thyroid gland which is induced by 
iodine deficiency. In the early stages of this lesion there is a diffuse 
enlargement of the gland, which is made up of small follicles. In later stages, 
some of the follicles may become distended and may coalesce to form 
nodules ranging in various sizes. The degenerative changes, usually occur in 
the nodules such as haemorrhage, necrosis, cyst and scar formation. The 
colloid goitre is the most common lesion which is often referred for 
aspiration. The colloid appears as pink homogeneous material in microscopy 
and is usually surrounded by a few follicular cells. 
 GRAVE’S DISEASE 
[16]
 
 It is a form of primary thyroid hyperplasia. The aspirates in this 
disease presents with moderate to high cellularity and a colloid-free bloody 
background. The follicular cells are arranged in monolayered sheets or can 
be arranged in follicles. The cytoplasm is moderate in amount and is pale in 
color and vacuolated. 
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INFLAMMATORY LESIONS  
ACUTE THYROIDITIS 
It can be suppurative or nonsuppurative.The etiology can be bacterial, 
fungal or it may be associated with radiation and is usually of infectious 
nature.
[13] 
HASHIMOTO’S THYROIDITIS 
It is the most common cause of autoimmune thyroiditis reported by 
Hakaru Hashimoto in 1912. The other name of this thyroiditis is “ Struma 
lymphomatosa”. The etiology is mostly due to effect of autoantibodies that 
alter the thyroid function. The immune-mediated injury of the thyroid gland 
leads to diffuse or nodular enlargement of the gland and then leading to 
exhaustion atrophy which is then manifested by diffuse oxyphilia of the 
follicular epithelium. The etiological factors leading to autoimmune 
thyroiditis are of both humoral and cellular nature.There are circulating 
autoantibodies which are present against thyroglobulin and other follicular 
cell antigens, and other thyroid follicle receptors like thyrotropin (TSH) 
receptors. The main etiology of this type of thyroiditis is due to organ-
specific defect in suppressor T lymphocytes. Therefore it is concluded that 
the etiology of autoimmune thyroiditis is multifactorial and is therefore of 
variable penetrance.
[14]
 
The smears in this type of thyroiditis composed of mixture of 
lymphocytes and oncocytes or Hürthle cells. The smear in Hashimoto’s 
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thyroiditis may resemble an aspirate of a hyperplastic lymph node. There is 
striking, abundant, eosinophilic and granular cytoplasm and there is 
variability in nuclear sizes. The nuclei contains large nucleoli and contain 
large intranuclear cytoplasmic inclusions. Sometimes the follicular cells in 
clusters may mimic a papillary carcinoma.  
The ‘lymphocytic’ type of HT is mostly seen in children and young 
adults. The smears show characteristic reactive lymphoid proliferation. The 
histiocytes have abundant amount of pale cytoplasm with granular 
chromatin. The florid type of HT occurs in older individuals who are 
hypothyroid. 
The aspirate smear shows lymphocytes admixed with variable number 
of plasma cells. There is prominent oxyphilic change.  
SUBACUTE GRANULOMATOUS THYROIDITIS (De QUERVAIN’S) 
This type of thyroiditis is probably of viral etiology and is of self 
limiting in nature. It occurs predominantly in females usually in the second 
to third decade of life after a respiratory infection and presents with clinical 
symptoms like sore throat, painful deglutition, and marked tenderness on 
palpation in the thyroid region, and often associated with fever and malaise. 
Histologic examination shows areas of marked inflammation and 
granulomas containing foreign body type of giant cells. The Smears in 
Granulomatous thyroiditis shows large multinucleate giant cells having 
numerous nuclei and granulomatous aggregates of epithelioid cells, and 
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degenerating follicular cells, neutrophils, macrophages and lymphocytes in a 
dirty smear background that shows debris. 
REIDEL’S THYROIDITIS 
This type of thyroiditis presents with an extensive sclerosis of the 
thyroid gland. The sclerosis is sometimes also associated with a similar 
tissue reaction in the mediastinum, retroperitoneum, and orbit. The 
consistency of thyroid gland is rubbery or firm and the aspirations are very 
minimal due to extensive desmoplastic reaction in the thyroid stroma. Due to 
its firm nature this type of thyroiditis must be differentiated from infiltrating 
carcinoma. 
[2] [15] 
TUMORS OF FOLLICULAR OR METAPLASTIC EPITHELIUM
 
FOLLICULAR ADENOMA 
Follicular adenoma is the most common type of thyroid neoplasm and 
lacks evidence of capsular or vascular invasion. 
[10]
 The aspirates are cellular 
with little colloid. The smears contain large clusters of follicular cells 
arranged in flat follicular or papillary structures or aggregates. The tumor 
cells may also form small rosette-like acinar clusters containing inspissated 
colloid. Single follicular cells and nuclei stripped of cytoplasm (“naked 
nuclei”) are seen scattered throughout the smear. The anisonucleosis may be 
present.  
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PAPILLARY CARCINOMA 
 They are the most common malignant tumors of the thyroid and 
usually presents as a palpable thyroid nodule. These malignancies are 
predominantly seen in females but sometimes may be seen in males and few 
cases also present in children. The smears are very cellular and the pattern of 
arrangement is predominantly in anastomosing papillary fragments but can 
be arranged as follicular structures, or in monolayered sheets generally free 
of colloid. The papillary pattern of arrangement is diagnostic of this tumor. It 
is common to find psammoma bodies in this cancer. The individual tumor 
cells, are usually larger. The cytoplasm is basophilic with sometimes discrete 
vacuoles can be seen. The nuclear features are very characteristics for this 
malignancy.The common nuclear features is the prescence of “ground-glass” 
nuclei and small central nucleoli. There is prescence of intranuclear 
cytoplasmic inclusions. Another characteristic nuclear feature is the 
prescence of nuclear grooves. The most important diagnostic feature is 
prescence of intracytoplasmic nuclear inclusions. The variants of papillary 
carcinoma include : 
1. Cystic papillary carcinoma. 
2. Follicular variant of papillary carcinoma. 
3. Tall-cell variant of papillary carcinoma. 
4. Warthin's-like variant of papillary carcinoma. 
5. Diffuse sclerosing variant of papillary carcinoma in childhood. 
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FOLLICULAR CARCINOMA
 
It is a rare neoplasm of thyroid showing invasion of capsule, blood 
vessels, or adjacent thyroid parenchyma. It also has predilection for 
women.The smears are cellular. Its microscopic appearance ranges from well 
formed follicles to solid growth pattern.
[10] 
Thus, they may closely resemble 
the cytologic feature of follicular adenoma. In the well-differentiated form of 
follicular carcinoma, cellular atypia is minimal, and the smear may suggest a 
benign lesion. In such cases, the cytologic diagnosis should be “follicular 
neoplasm or tumor,” clearly indicating that surgical excision and histologic 
examination is mandatory for a confirmed diagnosis. 
HURTHLE CELL (ONCOCYTIC) TUMORS  
Tumors in this category are composed of > 75% of follicular cells 
exhibiting oncocytic features. Most patients are adults, with a predominance 
in females.
[10]
 The majority are benign and are designated as Hurthle cell 
adenoma. In aspirations the cells are of uniform size and shape and they 
form tight clusters. The nuclei are large, vary in size, and may contain visible 
nucleoli. The most important differential diagnosis of Hürthle cell tumor is 
Hashimoto's thyroiditis with little or no lymphocytic component. Tumors 
with clear capsular or vascular invasion are called as Hurthle cell 
carcinoma.
[2] 
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POORLY DIFFERENTIATED (INSULAR ) CARCINOMA 
This tumor occurs in older age but can occur in adolescents also. This 
tumor shows a characteristic nesting (insular) pattern, small uniform tumor 
cells, variable mitotic activity, tumor necrosis resulting in a peritheliomatous 
pattern.
[10] 
UNDIFFERENTIATED CARCINOMA
 
This tumor most commonly presents in older individuals. 
Extrathyoidal extension is present in most cases. There are two forms of 
anaplastic carcinoma: a giant cell carcinoma and a small-cell-type 
carcinoma. 
[2]
 Smears of aspirates from the anaplastic giant cell carcinoma 
contain usually necrotic matter, cellular debris, inflammatory cells, mainly 
granulocytes, and large polymorphous, often multinucleated cells with large 
bizarre nuclei and very prominent nucleoli and in the small-cell variant of 
anaplastic carcinoma, the aspirate contains malignant cells with round or 
oval nuclei and scanty cytoplasm. 
[2] [10]
. 
MEDULLARY CARCINOMA 
It is a distinctive type of thyroid tumour composed of C(parafollicular) 
cells. The various morphological presentation of cell include plasmacytoid, 
small cell, spindle cell. Moderate anisonucleosis may be present and contains 
scattered large nuclei, which can be binucleate and multinucleate forms, 
there is ‘neuroendocrine’ type of uniform, stippled nuclear chromatin. The 
stroma is often vascular and contains hyalinised collagen and amyloid 
[2] [10]
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LYMPHOMA  
The primary lymphomas of thyroid,are of B-cell derivation, and is 
seen in patients with Hashimoto's thyroiditis.The smear contains lymphoma 
cells admixed with epithelial components.The majority of lymphomas arise 
primarily in the gland itself but may later involve lymph nodes and other 
organs. 
METASTATIC TUMORS IN THYROID 
The clinical presentation under this category can present as nodular or 
diffuse pattern. In nodular presentation the nodules can present as single or 
multiple or the metastasis can involve the whole gland and present in a 
diffuse pattern involving the entire gland. The metastases may sometimes 
mimic primary tumors of the thyroid. The distinction between a metastasis 
and primary thyroid tumor may sometimes be difficult. For example, in 
metastatic renal cell carcinoma cells may be elongated, or spindle in shape 
which mimics the cells seen in medullary carcinoma.  
If the malignant cells in the aspirate demonstrates cytologic features 
like keratinization, the prescence of mucin, the prescence of melanin, or cells 
with abundant clear cytoplasm, which are usually not seen in primary tumors 
of thyroid a diagnosis of metastasis may be suggested. 
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[TABLE 1]: Approximate percentage of various thyroid malignancies
[1] 
TYPE OF MALIGNANCY PERCENTAGE 
Papillary carcinoma 70-80 % 
Follicular carcinoma 10-20% 
Medullary carcinoma 5-10% 
Anaplastic carcinoma 2-10% 
Poorly differentiated carcinoma 0.4-10% 
Lymphoma 4-5 % 
   Expressed as the proportions of all thyroid malignancies 
The above table shows the distribution of percentage of various thyroid 
malignancies encountered. 
FINE NEEDLE ASPIRATION CYTOLOGY
 
It is one of the primary investigation used for the management of 
thyroid lesions, and its interpretation is very crucial for diagnosis
[18]
. 
HISTORICAL HIGHLIGHTS 
FNA has been shown to be the safest and most accurate of diagnostic 
tools in thyroid lesions.
[19] 
The fine needle aspiration method for studying 
thyroid was first done in Sweden in 1950s and its utility as a diagnostic 
protocol was established.
[20] 
Imprints during frozen section are very useful in 
identification of follicular variant of papillary carcinoma (FV-PC) as the 
characteristic nuclear morphology is better seen by this procedure.
[21] 
The 
US-guided FNA of thyroid is especially useful in cystic and multinodular 
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lesions harboring malignancy.
[22] 
Various modifications have been 
introduced to the Fine needle aspiration cytology technique. Santos JEC and 
Leiman G in 1988 pioneered a technique, non aspiration of fine needle 
cytology to study nodular lesions. This technique eliminates the active 
aspiration which is replaced by the principle of capillary suction of fluid or 
semisolid material into thin channel of the needle.
[23]
. Another development 
is the ultrasound guided FNAC which has proved to be beneficial in non - 
palpable nodules. Liquid based preparation is advocated as an adjunct to 
conventional smears. Its main advantages are reduction in number of slides 
to be screened, ability to perform immunocytochemical and other special 
stains and enhancement of nuclear details and irregularities of papillary 
carcinoma.  
Orell has defined the main indications for thyroid FNAC, they are 
[24] 
1. Diagnosis of diffuse non – toxic goitre. 
2. Diagnosis of solitary thyroid nodule. 
3. Confirmation of a malignancy. 
4. To obtain material for defining prognostic parameters. 
ADVANTAGES OF FNAC  
1. The technique is simple, safe, cost effective and can be done as an out 
patient procedure. 
2. Time required is very less and it’s interpretation is rapid.  
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3. Representative sample is drawn, while maintaining steady suction in 
various areas of the nodule. 
4. Cysts can be aspirated completely and thus it acts as a therapeutic 
procedure for the patient. 
5. Its main purpose is to provide a rational approach to management. 
DISADVANTAGES OF FNAC 
Minimal material available for examination. Architecture,cell relationship 
are absent.
[25]
 
1. The needle may miss important areas of the nodule despite a good 
attempt for a representative smear by aspiration from different areas. 
2. Distinction between a follicular adenoma and follicular carcinoma is 
difficult.
[26]
 
COMPLICATIONS   
FNAC is considered simple and safe procedure. It is rarely associated 
with complications as described below.
[27] 
1. Local discomfort. 
2. Minor hematoma. 
3. Puncturing carotid artery, internal jugular vein, which is very rare. 
4. Seeding of tumour along the needle track, though theoretically 
possible, the reported cases in world literature are anecdotal.
[28, 29]
 
5. Transient nerve palsy.
[30]
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PITFALLS OF FNAC 
1. Inadequate sampling : The aspirate may be cell poor as in Reidel’s 
thyroiditis and a second attempt becomes mandatory. 
2. Geographical misses: In such cases prior ultrasound may delineate the 
area of interest.  
The lack of a standardized reporting format has caused confusion and 
ambiguity in interpreting FNAC results. To address this need, the 2007 
National Cancer Institute State of the Science Conference proposed a 
uniform classification scheme named Bethesda with 6 distinct diagnostic 
categories for classifying the various thyroid disorders. 
THE BETHESDA SYSTEM OF THYROID CYTOPATHOLOGY 
[TABLE-2] 
The National cancer institute (NCI) hosted the State Of Science 
Conference on thyroid fine needle aspiration. The meeting took place on 
October 22 and 23, 2007, in Bethesda. The result of the meeting proposed a 
uniform classification system for identifying the thyroid lesions and named 
the classification as Bethesda system for reporting thyroid cytology which 
had six diagnostic categories as mentioned in [TABLE-2].
[32]
 
The Bethesda system recommends that each thyroid FNA should be 
reported under this classification to avoid confusion in manangement and to 
have a uniform communication between different clinicians as each category 
has its own implied cancer risk and each category is managed 
separately.[TABLE -2] 
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[TABLE -2 ] :  The Bethesda system of classification 
CATEGORY 
I 
Non -diagnostic/ 
Unsatisfactory 
Cyst fluid only 
Virtually Acellular smear 
Others (Obscuring blood/Drying artefact) 
CATEGORY 
II 
Benign Consistent with benign follicular nodule 
(Adenomatoid nodule, colloid nodule etc) 
Consistent with lymphocytic (Hashimoto) 
thyroiditis in proper clinical context 
Consistent with granulomatous (subacute ) 
thyroiditis 
Other 
CATEGORY 
III 
Atypia of 
undetermined 
significance or 
follicular lesion of 
undetermined 
significance 
 
CATEGORY 
IV 
Follicular 
neoplasm/ 
suspiciousof 
follicular neoplasm 
 
CATEGORY 
V 
Suspicious for 
malignancy 
Suspicious for papillary carcinoma 
Suspicious for medullary carcinoma 
Suspicious for metastatic carcinoma 
Suspicious for lymphoma 
Other 
CATEGORY 
VI 
Malignant Papillary thyroid carcinoma 
Poorly differentiated carcinoma 
Medullary thyroid carcinoma 
Undifferentiated (anaplastic carcinoma) 
Squamous cell carcinoma 
Carcinoma with mixed features 
Metastatic carcinoma 
Non – Hodgkin lymphoma 
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CRITERIA FOR ADEQUACY 
A thyroid FNA sample is considered adequate for evaluation if it 
contains a minimum of six clusters of well visualized thyroid follicular cells, 
and there should be atleast ten cells per cluster. 
NON DIAGNOSTIC- UNSATISFACTORY FOR EVALUATION 
A specimen is considered Non – diagnostic 
[31]
 if it does not contain 
the adequate clusters recommended for a definite diagnosis. An adequate 
FNA smear contains a minimum of six clusters of well visualized thyroid 
follicular cells, with atleast ten cells per cluster, a smear is considered non-
diagnostic when it fails to meet the adequacy criteria. Few cystic lesions are 
also considered non-diagnostic when it shows only cyst macrophages and 
very fewer benign thyroid follicular cells. 
BENIGN FOLLICULAR NODULE [BFN] 
  This smear contains predominantly of colloid and benign-appearing 
thyroid follicular cells. The other terms like colloid nodule, nodular goiter 
adenomatoid nodule, Graves’ disease are used depending upon the clinical 
presentation and features of thyroid follicular cells. The sample is 
moderately cellular, and when colloid is present it can be thick or thin and 
has a viscous or shiny appearance, or sometimes have brown color in nature. 
The prescence of colloid gives a definite background to the smear, thin 
colloid gives a crazy pavement like background and thick colloid gives a 
cracking artefact like appearance to the smear.
[32]
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  The arrangement of thyroid follicular cells is predominantly in 
monolayered sheets sometimes the follicular cells may be seen arranged in 
clusters also. The individual follicular cells have moderate amounts of 
cytoplasm with dark, round to oval nuclei and a granular chromatin. 
Anisonucleosis if present is very mild. The abundance of colloid with 
honeycomb-like arrangement of follicular cells and occasionally admixed 
with few Hurthle cells if any is the hallmark of BFN. 
 Sometimes the smear in BFN contains thyroid follicular cells which 
have nuclear features suggestive of a papillary thyroid carcinoma. Such 
smears are better interpreted as “Suspicious for malignancy” or “Atypia of 
Undetermined Significance (AUS)”, depending on the extent of atypia.
[
 
33,34,35]
 
GRAVE’S DISEASE  
 It is a diffuse hyperplastic thyroid disorder which is mostly 
autoimmune, mainly seen in middle-aged females and presents with features 
of hyperthyroidism. The smears are cellular admixed with lymphocytes, 
oxyphilic cells. The pattern of arrangement of follicular cells is seen in flat 
sheets and loose groups, the individual thyroid follicular cells have abundant 
cytoplasm and there is often enlarged nuclei sometimes it can be vesicular 
with prominent nucleoli. 
[36] 
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LYMPHOCYTIC (HASHIMOTO’S ) THYROIDITIS 
  This thyroiditis is mostly seen in middle-aged females. The clinical 
presentation is mostly diffuse enlargement of thyroid, but sometimes can 
present as nodular swelling which then warrants a FNAC to be done.  
DEFINITION 
The term “Consistent with lymphocytic (Hashimoto’s) thyroiditis” 
refers to a smear which is exclusively composed of many lymphocytes 
admixed with few Hurthle cells along with the thyroid follicular cells.
[37]
 
CRITERIA 
  The smears are hypercellular. In this diagnostic category a minimum 
number of follicular/Hürthle cells is not needed for adequacy to interpret.
[38] 
There is  polymorphic lymphoid population admixed with occasional plasma 
cells and germinal center like lymphoid follicles may be seen sometimes in 
the background smear. The oxyphilic cells if they are present, they are 
usually arranged in sheets or seen as isolated cells. The oncocytes have 
abundant granular cytoplasm, large nuclei, and prominent nucleoli 
sometimes mild anisonucleosis is seen. 
GRANULOMATOUS (SUBACUTE/De QUERVAIN’S THYROIDITIS) 
This is a inflammatory condition of thyroid which is usually self –
limited and diagnosed on clinical routine. There is usually a diffuse 
presentation but when nodularity is present an FNA is generally performed 
in the patient. However the cytologic findings are nonspecific if there is 
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absence of granulomas. Due to inflammatory condition the biopsy procedure 
may be quite painful for the patient and thus leading to inadequate sampling. 
CRITERIA 
There is variable cellularity and the cellularity depends on the stage of 
disease. There is prescence of clusters of epithelioid histiocytes. 
[39]
 Different 
stages of presentation depends on different features in smears. In early stage 
of this type of thyroiditis there is lot of neutrophils seen in the smear and it 
resembles as that of acute thyroiditis and in the later stages the samples are 
hypocellular and they show giant cells surrounding the colloid and 
sometimes seen engulfing it , epithelioid cells, lymphocytes, macrophages, 
and scant degenerated follicular cells are also seen.
[39]
 In the involutional 
stage of this disease the giant cells and inflammatory cells are absent in the 
smear. 
ACUTE THYROIDITIS 
This type of thyroiditis is most commonly seen in 
immunocompromised individuals and is considered as a infectious condition 
of thyroid and with very rare presentation. 
CRITERIA 
The smears are dominated by the presence of numerous neutrophils 
which are seen admixed with necrosis, fibrin, macrophages in a 
haemorrhagic background in the background of few scant reactive follicular 
cells. 
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RIEDEL’S THYROIDITIS 
This type of thyroiditis is very rare in presentation and there is 
extensive fibrosis of the thyroid and also involving the adjoining area in the 
neck thus leading to a consistency which is firm to stony hard. 
CRITERIA 
Due to the fibrosis involving the gland the cellularity is very scant and 
almost acellular in many. The smear shows few spindle cells admixed with 
collagen. Sometimes rare inflammatory cells may be seen in the smear. The 
thyroid follicular cells are almost absent in the smear. Colloid is also not 
discernible in the smear. 
ATYPIA OF UNDETERMINED SIGNIFICANCE / FOLLICULAR 
LESION OF UNDETERMINED SIGNIFICANCE 
DEFINITION 
 This term is used when the thyroid follicular cells show nuclear 
atypia and arranged in its own architectural pattern so that it becomes 
difficult to classify the lesions in any definite category like follicular 
neoplasm, suspicious for follicular neoplasm, suspicious for malignancy and 
malignant category. The patients diagnosed under this category are followed 
up periodically and a repeat aspiration/ biopsy is recommended after a 
specific period of time.
[40]
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CRITERIA  
 An AUS interpretation is appropriate in the cytological conditions 
which are mentioned below: 
1. When the smear shows a predominant clusters of microfollicles but 
the cellularity is very little so that it does not fulfill the criteria for 
“Follicular Neoplasm/Suspicious for Follicular neoplasm, or when the 
sample is markedly cellular but the proportion of microfollicles is not 
adequate to classify the lesion under the category of “Follicular 
Neoplasm/Suspicious for Follicular Neoplasm.”
[41]
 
2. The aspirate is very sparse and contains scant colloid admixed with a 
predominant population of Hürthle cells. 
3. Prescence of artefact interfering with follicular cell atypia like the air-
drying artefact which causes a slight nuclear and cytoplasmic 
enlargement and the clotting artifact associated with cellular 
crowding. 
4. When there is predominant population of Hürthle cells in a cellular 
smear. 
5. The smear shows nuclear features which are suggestive of papillary 
carcinoma like nuclear grooving and ground glass nuclei.  
6. The smear shows a small proportion of thyroid follicular cells with 
nuclear enlargement. 
7. The smear shows an atypical lymphoid infiltrate. 
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FOLLICULAR NEOPLASM / SUSPICIOUS FOR A FOLLICULAR 
NEOPLASM 
DEFINITION 
This diagnostic lesion implies to an aspirate which is markedly 
cellular and composed of thyroid follicular cells mainly arranged in a 
predominant microfollicle pattern.
[40,43]
 
CRITERIA 
There is a markedly cellular smear and the thyroid follicular cell are 
arranged as microfollicle pattern. The thyroid follicular cells are relatively 
uniform, in size and have moderate amounts of cytoplasm. The nuclei are 
uniformly round with slight hyperchromatism and no nucleoli. 
[44] 
The 
hallmark of this category is microfollicular pattern. The “microfollicle” 
pattern refers to the arrangement of follicular cells in flat groups with less 
than 15 cells per group and the cells are arranged in a
 
circle that is at least 
two-thirds complete.The microfollicle sometimes may contain a small 
amount of colloid. The size of the microfollicles tend
 
to be uniform. When 
the sample is sparsely cellular and the smear contains predominantly 
microfollicles, it is advisable to classify such lesions under the category of 
ATYPIA OF UNDETERMINED SIGNIFICANCE and the patients are 
managed according to the category. The parathyroid adenomas when 
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aspirated the smears show crowded and overlapping follicular cells which 
are uniform in size so they are often misinterpreted as FN/SFN. 
FOLLICULAR NEOPLASM, HURTHLE CELL TYPE/ SUSPICIOUS 
FOR A FOLLICULAR NEOPLASM,HUTHLE CELL TYPE 
The Hürthle cell is also called Askanazy cell because its named after 
its discoverer and the other names of Hurthle cells include oxyphilic cell, 
and oncocyte, the Hurthle cell is defined as a thyroid follicular cell which is 
large in size with abundant granular cytoplasm and have enlarged round to 
oval nucleus with prominent nucleoli. These cells are commonly seen in 
some reactive or hyperplastic conditions like lymphocytic (Hashimoto’s) 
thyroiditis (LT) and multinodular goiter (MNG) these cells are considered as 
metaplastic, non-neoplastic follicular cells in these conditions but the 
Hurthle cells can be seen in neoplastic conditions like (Hürthle cell adenoma 
and Hürthle cell carcinoma). 
[40,45,46] 
DEFINITION 
This category comprises of a smear that is markedly cellular and 
consists predominantly of Hürthle cells.  
CRITERIA 
The Hürthle cells in smear have abundant granular cytoplasm which 
stains pink with hematoxylin and eosin and the nucleus is large and may be 
central or eccentric in location with prominent nucleoli.The Hürthle cells are 
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predominantly seen as singly scattered cells, but sometimes these cells can 
also be seen in crowded clusters or in syncytial pattern.  
There are three problematic features in diagnosing a minimum criteria 
of FNHCT/SFNHCT, these include 
1. when the smear is sparsely cellular and is predominantly composed of 
Hürthle cells;  
2. when the smea is moderately-to-markedly cellular and exclusively 
composed of Hürthle cells without atypia; 
3. An abnormal smear which shows partial or minimal Hürthle cell 
differention. 
In a FNA procedure when the smear shows <75% of the large cells are 
Hürthle cells it should be classified as “Follicular Neoplasm/Suspicious for a 
Follicular Neoplasm” rather than the FNHCT/SFNHCT
. [47,48]  
The differential diagnosis of FNHCT/SFNHCT includes the neoplasms like 
Papillary carcinoma of thyroid , the HCNs may show papillary pattern of 
arrangement with characteristic nuclear features of papillary carcinoma and 
conversely the cells in classic papillary carcinomas of thyroid often shows 
focal oncocytic differentiation. This feature is particularly seen in the 
oncocytic variant of papillary carcinoma 
[40,49] 
Another differential diagnosis of HCNs is medullary carcinoma. The 
medullary carcinomas are composed of cells which have abundant amount of 
fine granular cytoplasm thus confusing with a Hurthle cell. The Hurthle cell 
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contains prominent nucleoli which is almost absent in most medullary 
carcinoma.On staining with Romanowsky stains, the cytoplasmic granules of 
Hürthle cells are stained blue in color whereas in medullary carcinoma the 
cytoplasmic granules are stained usually red.  
In parathyroid adenomas the cells mimicks like the cells of HCNs but 
the arrangement of the cells in parathyroid adenomas in monomorphous 
pattern and the nuclei showing features of “salt and pepper” chromatin are 
not seen in HCN.
[50]
 
SUSPICIOUS FOR MALIGNANCY 
DEFINITION 
This category of suspicious for malignancy (SFM) is reported when 
the smear shows strong features of malignancy (mainly papillary thyroid 
carcinoma ) but the cytological findings present in the smear are not definite 
to make a conclusive diagnosis of malignancy.
[51]  
Such diagnostic category 
is created with the aim of acheiving a very high positive predictive value of 
the malignant lesions 
 
CRITERIA 
SUSPICIOUS FOR PAPILLARY CARCINOMA
[52,53] 
Pattern A (Patchy Nuclear Changes Pattern) 
In this pattern the smear is highly cellular.The pattern of arrangement 
is in macrofollicle clusters and some of the cells show characteristics nuclear 
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features of papillary carcinoma such as nuclear grooves,nuclear molding, 
and nuclear pseudoinclusion. 
Pattern B (Incomplete Nuclear Changes Pattern)
[54]
 
 
In this pattern the aspirate is of variable cellularity.The smear obtained 
can be sparsely cellular, moderately, or highly cellular. The nucleus shows 
features of papillary carcinoma but in an incomplete pattern, there is 
prescence of mild nuclear atypia and pallor the nuclear grooves are seen but 
the characteristic intranuclear pseudoinclusions are not present. 
Pattern C (“Sparsely Cellular Specimen Pattern”) 
In this category the smear although it is sparsely cellular but it 
contains many features of papillary thyroid carcinoma. 
Pattern D (Cystic Degeneration Pattern)
[59] 
 This pattern shows features of cystic degeneration such as the 
presence of cystic macrophages laden with hemosiderin. The arrangement of 
thyroid follicular cells is seen mainly in clusters or in diffuse sheets and the 
individual cells have large pale nuclei and some of the nucleus shows 
nuclear grooves, but the intranuclear inclusions are absent and there is 
prescence of occasional “histiocytoid” type of cells which have enlarged 
nuclei and abundant vacuolated cytoplasm. 
[57,58,59] 
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SUSPICIOUS FOR MEDULLARY CARCINOMA 
The smear is sparsely cellular. The smear shows a uniform population 
of single dispersed small to medium sized cells. The nuclear cytoplasmic 
ratio is high and the nuclei is eccentrically located, and shows smudged 
chromatin and admixed in a background of amorphous material. 
SUSPICIOUS FOR LYMPHOMA 
The smear can be cellular or sparsely cellular. When the sample is 
cellular it is composed of numerous population of monomorphous 
population of lymphocytes. When the smear is sparse in cellularity the 
atypical lymphocytes may be present. 
SUSPICIOUS FOR MALIGNANCY, NOT OTHERWISE SPECIFIED 
The other thyroid malignancies which are encountered in thyroid if 
present can cause poor cellularity and thus a diagnosis of SFM is opted in 
such conditions. 
PAPILLARY THYROID CARCINOMA AND ITS VARIANTS
[60,61] 
 The most common malignancy in thyroid is papillary thyroid 
carcinoma and it constitutes for about 70- 80% of all cancers seen in thyroid 
and is seen predominantly in females in the age group of 30’s to 40s. 
External radiation to the neck during childhood presents as a risk factor for 
this malignancy. The clinical presentation is usually as a nodular lesion. 
Papillary thyroid carcinoma usually spreads via lymphatics to the lungs. The 
prognosis of papillary thyroid carcinoma is good. 
[53]
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DEFINITION 
Papillary thyroid carcinoma is a malignant epithelial tumor which 
shows peculiar nuclear features. The pattern is papillary.
[53] 
CRITERIA 
  
The thyroid follicular cells are arranged in papillary pattern or as in 
diffuse sheet like pattern. The nuclear features of papillary carcinoma are 
very characteristic and mentioned below: 
1. Nuclei are enlarged which can be oval or irregularly shaped with some 
nuclei may show molding.  
2. Longitudinal nuclear grooves are present. 
3. Intranuclear cytoplasmic pseudoinclusions. 
4. The nuclei is pale (“Orphan Annie” nuclei). 
5. The nucleoli is small and can be solitary or multiple. 
6. Psammoma bodies are sometimes present. 
7. Multinucleated giant cells are common. 
8. The colloid is variable and may be stringy, ropy, or “bubble-gum”-like  
consistency. 
VARIANTS OF PAPILLARY CARCINOMA
[60,61] 
 DEFINITION 
These lesions have the characteristic nuclear features of Papillary 
thyroid carcinoma but architectural pattern is different, the prescence of 
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colloid and its consistency and there is a lymphoplasmacytic infiltrate in the 
background of the smear which can be prominent if present or it can be 
absent. 
FOLLICULAR VARIANT OF PAPILLARY CARCINOMA 
DEFINITION 
This variant is the most common variant of papillary carcinoma and is 
composed of thyroid follicles which are small to medium-sized and have 
peculiar nuclear features of papillary carcinoma of thyroid.There is a 
predominant microfollicle type of arrangement in the smear and sometimes 
the smear may be composed of normal sized follicles. And if in this variant 
the smear is composed predominantly of macrofollicle clusters it is 
considered as a different entity. 
[63,64]
 
CRITERIA  
Smears are hypercellular, with arrangement of thyroid follicular cells 
in syncytial sheets and in microfollicles.Some thick colloid may be present 
within the neoplastic follicle. The nuclear changes are subtle. 
MACROFOLLICULAR VARIANT OF PAPILLARY 
CARCINOMA
[65,66] 
 DEFINITION 
This variant of papillary thyroid carcinoma contains thyroid follicles 
arranged predominantly in macrofollicle clusters. 
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CRITERIA 
The smear consists of diffuse sheets of variably sized follicles. The 
nuclear features are essential for a conclusive evidence of malignancy. The 
background of the smear shows lot of thin or thick colloid. The differential 
diagnosis of this variant includes the nodular goiter in a benign follicular 
nodule and the follicular adenoma of the macrofollicular type
[
.
66,67]
 
CYSTIC VARIANT OF PAPILLARY CARCINOMA
[68] 
DEFINITION 
This variant is predominantly cystic and composed of thin cystic fluid, 
with abundant macrophages.
[57] 
CRITERIA
 
The thyroid follicular cells are seen as sheets, papillae, or follicles. 
Tumor cells are “histiocytoid” in appearance with hemosiderin laden 
macrophages admixed with thin colloid. The nuclear characteristics of 
papillary carcinoma are essential for a conclusive diagnosis of this 
malignancy . 
ONCOCYTIC VARIANT OF PAPILLARY CARCINOMA
[70]
 
DEFINITION
 
In this category the follicular cells have characteristic nuclear features 
of papillary carcinoma and are seen admixed with a prominent population of 
oncocytic cells. The oncocytic cells are round to oval with abundant granular 
eosinophilic cytoplasm.
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CRITERIA 
In this category the smear shows a predominant population of 
oncocytic cells which are commonly arranged in papillary pattern or in 
diffuse sheets or as single cells but the nuclear peculiarity of papillary 
thyroid carcinoma are mandatory for a conlusive evidence of this variant. 
[70,71]
 
WARTHIN LIKE VARIANT OF PAPILLARY CARCINOMA
[72] 
DEFINITION 
This category presents as a circumscribed thyroid neoplasm with a 
papillary pattern of arrangement and usually admixed with lymphoid 
follicles that mimics the Warthin tumor of parotid gland.  
CRITERIA 
The follicles are arranged in papillary pattern and composed 
predominantly of thyroid follicular cells which are predominantly oncocytic 
and also some of the cells are present as singly dispersed cells admixed in a 
lymphoplasmacytic background. The nuclear characteristics of papillary 
thyroid carcinoma are a must for a conclusive evidence. 
TALL CELL VARIANT OF PAPILLARY CARCINOMA
[73,74] 
DEFINITION 
This variant is an aggressive form of papillary thyroid carcinoma and 
is composed of thyroid follicular cells arranged in papillary pattern the 
individual thyroid follicular cells are elongated and arranged in single layer 
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which have abundant cytoplasm which is dense and granular and contains 
the characteristic nuclear features of papillary thyroid carcinoma. 
CRITERIA 
Tall cells with abundant cytoplasm should be present in more than 
50% of the tumor mass to allow it to be classified as a tall cell variant of 
papillary carcinoma with characteristic nuclear features are present for a 
definite diagnosis of this variant. The chromatin is more granular with few 
psammoma bodies and intranuclear inclusions are more frequently present.  
COLUMNAR CELL VARIANT OF PAPILLARY CARCINOMA 
[75]
 
DEFINITION 
This variant is aggressive and is composed predominantly of columnar 
cells which have cytoplasmic vacuoles which can be supranuclear or 
subnuclear. The neoplastic cells are commonly seen as papillary pattern, but 
trabecular and follicular arrangement can also be seen. 
CRITERIA 
Aspirates are cellular and there is no colloid in the background. The 
tumor cells are arranged in papillary pattern, in groups, and diffuse sheets, 
and sometimes seen as small tubules. There is elongation and stratification of 
nuclei. And as a rule the characteristic nuclear features of papillary thyroid 
carcinoma are a must to conclude a conclusive evidence. 
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HYALINIZING TRABECULAR TUMOR
[76]
.
 
DEFINITION 
This tumor shows the thyroid follicular cells arranged in trabeculae 
and there is hyalinization in between the trabeculae growth and most 
important feature is that it contains the nuclear peculiarities of papillary 
thyroid carcinoma. 
CRITERIA 
The tumor cells are arranged around a hyaline stromal material.The 
nuclear features like intranuclear inclusions and nuclear grooving are 
present.  
There is a confusion regarding considering this tumor as a variant of 
papillary thyroid carcinoma or as a form of follicular adenoma. Because of 
its nuclear features, these tumors are mostly interpreted as papillary thyroid 
carcinoma or “suspicious for papillary thyroid carcinoma.
[77]
 
MEDULLARY THYROID CARCINOMA 
Medullary thyroid carcinoma constitutes of about 7% of thyroid 
malignancy.There are two forms of appearance in this tumor sporadic and 
heritable forms. The heritable forms include the multiple endocrine neoplasia 
(MEN) type 2A (Sipple’s syndrome), which includes mainly 
pheochromocytomas and hyperparathyroidism in some families; MEN type 
2B (mucosal neuroma syndrome or Gorlin’s syndrome), which mostly 
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includes mucosal neuromas and with somatic marfanoid habitus; and 
admixed with familial medullary thyroid carcinoma (FMTC).
[78]
 
DEFINITION 
It is a malignant neoplasm and is derived from the parafollicular cells 
of the thyroid gland. 
CRITERIA OF MTC 
The aspirates are moderate to markedly cellular. The thyroid follicular 
cells are single cells alternating with cells in syncytial clusters. The 
individual tumor cells are plasmacytoid, polygonal, round, and/or spindle-
shaped. And a mild nuclear pleomorphism is usually seen. The nuclei are 
often round and the chromatin can be fine or coarsely granular (“salt and 
pepper”) chromatin. Occasionally the pseudoinclusions in nucleus are 
present and often the nucleus can be binucleated and multinucleated. There 
is inconspicuous nucleoli but sometimes it can be prominent also. The 
cytoplasm is granular and variable The amyloid is often present in the smear 
and is seen as a dense, amorphous material. There is strongly 
immunoreactivity in tumor cells for calcitonin, CEA, chromogranin, 
synaptophysin, and TTF-1, and are negative for thyroglobulin.
[78,79]
 
 The most common differential diagnosis of medullary thyroid 
carcinoma is a Hürthle cell neoplasm but papillary carcinoma, anaplastic 
carcinoma, hyalinizing trabecular tumor plasmacytoma, and metastatic 
tumors like melanoma also warrant consideration in some instances. 
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Immunohistochemistry markers help in differentiation between these 
tumors.
[79]
 
POORLY DIFFERENTIATED CARCINOMA 
DEFINITION 
 In this category the thyroid follicular cells are arranged in insular, 
solid, or trabecular growth pattern. The pure form of poorly differentiated 
carcinoma lacks the characteristic nuclear features of papillary thyroid 
carcinoma but has peculiar features like mitoses, necrosis, or small 
convoluted nuclei. The most classic pattern of poorly differentiated thyroid 
carcinoma is the insular type of arrangement which is shown by cells 
arranged in nests or groups and shows a outlining of thin fibrovascular core. 
In a few cases poorly differentiated thyroid carcinoma can be seen admixed 
with well differentiated thyroid carcinoma like follicular carcinoma, 
papillary carcinoma.
[80] 
CRITERIA 
  The smears are cellular and shows a insular, solid, or trabecular 
pattern. The thyroid follicular cells are uniform with scant cytoplasm with 
occasional plasmacytoid appearance. The individual tumor cells show 
nuclear atypia which is variable.
[81]
 
UNDIFFERENTIATED (ANAPLASTIC) THYROID CARCINOMA  
This variant of thyroid carcinoma is also called as “giant and spindle 
cell carcinoma,” it is an aggressive thyroid malignancy which is extreme in 
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nature and accounts for less than 5% of thyroid malignancy. Prognosis is 
poor compared to other thyroid malignancy and there is a female 
predominance. There is a hard, nodular thyroid gland, and most of th e 
patients presents with a rapidly growing mass. There is marked tumor 
growth which leads to neck enlargement and may present with or without 
reactive fibrosis, and this may infiltrate into surrounding soft tissues of the 
neck.
[82]
 
DEFINITION 
Undifferentiated thyroid carcinoma is a high grade thyroid malignancy 
that is pleomorphic and composed of epitheloid and spindle cell features. 
CRITERIA 
Smears are variably cellular but there is usually marked cellularity. 
The tumor cells are arranged as single cells or in clusters. The tumor cells 
are epitheloid or spindle-shaped and they range in various sizes. The tumor 
cells can be plasmacytoid. The nuclei of the tumor cells show mild 
pleomorphism with some of the nucleus shows parachromatin clearing, with 
prominent irregular nucleoli, with some intranuclear inclusions, and in some 
cases the nucleus can be eccentrically placed, and often admixed with 
multinucleation. Background shows necrosis and there is extensive 
inflammation which is predominantly composed of neutrophils. In some 
cases the osteoclast-like giant cells may be present. The mitotic figures are 
increased in count and often numerous and abnormal.
[82] 
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SQUAMOUS CELL CARCINOMA OF THYROID 
 
This thyroid cancer accounts for less than 1% of all thyroid cancers. 
Like undifferentiated thyroid carcinoma, it usually occurs in elderly and has 
a poor prognosis. 
DEFINITION 
This diagnostic category includes a malignant tumor in thyroid that 
shows exclusively squamous differentiation. 
CRITERIA 
The smears in this category are almost exclusively composed of large, 
pleomorphic keratinized cells admixed with few areas showing necrosis. 
METASTATIC TUMORS IN THYROID 
The metastatic tumors in thyroid are very rare. It is important to 
recognize these lesions in fine needle aspiration smears of thyroid nodules. 
In some cases metastasis to the thyroid can be the initial presentation of a 
distant tumor. Tumors of the nearby organs like pharynx, larynx, esophagus, 
mediastinum, and the nearby lymph nodes can also involve the thyroid. The 
thyroid is most commonly metastazied in cancers of the lung, breast, skin 
and kidney. The metastatic carcinomas to thyroid can manifest as three 
patterns (1) they can present as multiple small discrete nodules (less than 2 
mm); (2) or they can present as solitary large nodules; and (3) or can involve 
as a diffuse involvement. 
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1. METASTATIC RENAL CELL CARCINOMA 
A majority of these lesions present as solitary or multiple nodules and 
the lesions from metastatic renal cell carcinomas are of clear cell type and 
they can occur after a long gap of even 20 years following the removal of the 
primary cancer in the patient.
[82] 
DEFINITION 
The metastatic renal cell carcinoma is a malignant tumor that is seen 
arising from any one of the kidneys and subsequently involves the thyroid 
gland. 
CRITERIA 
The aspirates are markedly cellular. The tumor cells are arranged in 
small clusters, fragmented papillae in sheets or can be seen as single 
dispersed cells. The individual tumor cells have abundant granular, clear or 
vacuolated cytoplasm. The nuclei are round to oval with prominent nucleoli. 
The aspirates are haemorrhagic.
[82,83]
 
2. METASTATIC MALIGNANT MELANOMA
[84 
It is a malignancy that is derived from the cells which are 
differentiating towards melanocytes that arises from the skin or, can arise 
from the extra-cutaneous sites and thus involves the thyroid gland. 
CRITERIA 
The smears are moderately cellular and most of the cells are 
noncohesive. The cells can be plasmacytoid, spindleshaped, and can present 
  
43 
 
as anaplastic forms. The nuclei are large and are often eccentrically placed. 
Sometimes intranuclear cytoplasmic pseudoinclusions can be seen. The cells 
are immunoreactive for S-100 protein, melanA, and HMB45.
[84]
 
METASTATIC ADENOCARCINOMA FROM BREAST 
DEFINITION 
It is an epithelial type of malignancy arising from the cells 
differentiating towards the ductal epithelium and involves the thyroid gland. 
CRITERIA 
The aspirates are moderately cellular and composed of 
monomorphous cells.The cells can be seen in single or in small clusters. 
METASTATIC PULMONARY CARCINOMA 
The smears from the bronchogenic carcinomas depends on the nature 
of primary tumor. The metastatic small cell carcinoma resembles the insular 
pattern of the thyroid carcinoma. The individual tumor cells in tumors like 
adenocarcinomas of pulmonary origin are composed of medium-sized to 
large sized cells that are seen in diffuse form or can be seen in clusters. The 
cells are columnar in appearance with round to oval and eccentric nuclei and 
with prominent nucleoli. 
MALIGNANT LYMPHOMA IN THYROID 
The Malignant lymphomas in thyroid can arise as a primary tumor or 
it can arise as a secondary as a manifestation of a systemic disease. Most of 
the primary thyroid lymphomas are of the B-cell type. The Lymphomas 
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constitutes about 5% of the thyroid neoplasms.Plasma cell malignancy in 
thyroid and Hodgkin lymphoma are rare malignancy in thyroid.
[85,86] 
EXTRANODAL MARZINAL ZONE B-CELL LYMPHOMA 
Aspirates are markedly cellular and there is prescence of lymphoid 
cells in clusters or as singly scattered. The individual cells are small in size 
and are about twice as bigger as that of a small lymphocyte. The individual 
tumor cells have moderate amount of cytoplasm vesicular nuclei and have 
open chromatin and nucleoli are present which are small. Another population 
of large cells are seen which have eccentric nuclei, coarse chromatin, and 
prominent nucleoli. These cells are often seen along with centrocytes,the 
monocytoid B-cells, and plasma cells. Sometimes the follicular and 
oncocytic type of thyroid epithelial cells are seen along with lymphoid 
cells
[85] 
DIFFUSE LARGE CELL LYMPHOMA 
The samples are cellular and there is often seen many 
lymphoglandular bodies in the background. The aspirates usually contain 
uniform and singly scattered large lymphoid cells. The nucleus shows coarse 
chromatin shows one to two prominent nucleoli.
[87] 
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THE BETHESDA SYSTEM FOR REPORTING CYTOPATHOLOGY: 
IMPLIED RISK OF MALIGNANCY AND RECOMMENDED  
CLINICAL MANAGEMENT 
[TABLE -3] : Risk of malignancy in different categories in Bethesda and 
proper management. 
Diagnostic Category Risk of 
malignancy(%) 
Usual management 
Non- diagnostic or 
unsatisfactory 
    - Repeat FNA with 
ultrasound guidance 
Benign 0-3 Clinical follow up 
Atypia of undetermined 
significance / Follicular 
lesion of undetermined 
significance 
5-15 Repeat FNA 
Follicular neoplasm / 
Suspicious for follicular 
neoplasm 
15-30 Surgical lobectomy 
Suspicious for malignancy 60—75 Near –total thyroidectomy 
 
Malignant 97-99 Total thyroidectomy 
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The TABLE-3 shows the risk of malignancy in each category of 
Bethesda and proper clinical manangement in each category. By classifying 
the thyroid lesions in these categories avoids the confusion in management 
of patients and thus helps in uniform communication among different 
clinicians and helps in proper patient management. In ND/UNS category, 
patients are managed by a repeat thyroid FNA which is done 3months later 
to avoid the false positive interpretation due to reparative change. In Benign 
category ,the patients are managed by regular follow up at 6-18 months 
interval for a period of 3-5 years. In AUS category the patients are managed 
by a repeat FNA after an appropriate interval and the mostly correlated 
clinically and the risk of malignanacy is close to 5-15%.In FN/SFN category 
the patients are usually managed by surgery which is usually a 
hemithyroidectomy or a lobectomy and the risk of malignancy is close to 15-
30%. In SFM category the patients are usually managed by a near – total 
thyroidectomy  as the risk of malignancy is hgher in this category and is 
almost close to 60-75%. In Malignant  category the patients are usually 
managed by a total thyroidectomy as the risk of malignancy is almost 97-
99%  . 
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                                        MATERIALS AND METHODS 
ETHICAL CONSIDERATION 
The study was conducted after obtaining approval from the 
Institutional Ethical Committee of Tirunelveli Medical College, Tirunelveli. 
This prospective study was carried out in the Cytopathology Laboratory of 
the Department of Pathology Tirunelveli Medical College, Tirunelveli from 
January 2013 to June 2014. All the paients who reported to the department of 
pathology with a requisition to perform FNAC with clinically detectable 
thyroid swelling were included in the study. 
A total of 300 cases was included in the study. The patients referred 
from Surgical OPD, Medicine OPD, ENT and other OPDs was included in 
the study. 
 A detailed clinical history was taken and recorded on a proforma with 
special emphasis on thyroid function. 
A detailed general examination was also carried out. Examination of 
the thyroid done as per the standard protocol and recorded in the proforma. 
Fine needle aspiration was carried out in the cytopathology laboratory. 
INCLUSION CRITERIA 
All patients who presented with thyroid swelling irrespective of age 
and sex. 
EXCLUSION CRITERIA 
The patients who had not given a written informed consent. 
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PROCEDURE 
All patients were seen and informed written consent was obtained 
from each patient prior to FNAC. 
After obtaining the consent and giving a brief explanation about the 
procedure to the patient, aspiration was done with the patient in supine or 
sitting position with hyperextended neck, so as to make the thyroid swelling 
prominent. 
Under aseptic precautions a 23 gauge needle with syringe was inserted 
into the lesion. Three to four to and fro movements were performed quickly. 
Under negative pressure, material gets collected in the needle. After 
collection of material, negative pressure was released, needle with syringe 
holder was removed. The material was spread over clean labelled slides and 
smears were prepared and stained by Hematoxylin and Eosin method(H&E). 
Whenever fluid was aspirated the whole content was aspirated and 
centrifuged and smears then made with the sediment and stained with H&E. 
In such cases whenever a residual mass was observed, it was reaspirated. In 
case of multiple nodules, more than one aspirate was done from prominent 
nodules. No serious complication occurred in our study.  
The cytopathology report was then given according to the standard 
reporting format as suggested by the Bethesda system for reporting thyroid 
cytopathology. 
  
  
                                OBSER
STUDY DESIGN [CHART
FNAC was done on 300 patients with the history of thyroid swellings
a period from January 2013 to June 2014. Of the 300 aspirations
aspirates were satisfactory
unsatisfactory.[CHART
CHART- 1 : Percentage of satisfactory and unsatisfactory smears in 
present study 
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VATION AND RESULTS 
-1]  
 smears and 3 smears were 
-1] 
 
 
 during 
, 297 
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AGE OF DISTRIBUTION [TABLE-4], [CHART -2] 
  In this study it was noted that the maximum clustering of cases 
occurred in the age group from second to and fourth decade of life (68%) 
between the age group of 20- 49 years. 
In this study the youngest patient with thyroid lesion was a 9 year old 
female and oldest one was a 85 years old female. The mean age is 38.3 years 
with a standard deviation of 14.917.  
It was noted that 2 cases presented with thyroid lesions in the age 
group of 0-9 years and both were benign lesions. 
The highest percentage of cases occurred in the age group of 30-39 
years. 
The age group of 20-29 yrs and 40-49 years had similar percentage of 
distribution of cases in this study. The remaining age groups had average 
number of cases. In the age group of > 70 years, 11 cases were present out of 
the total 300 cases in this study. 
The incidence of benign lesions (69.6%) were most commonly seen 
from second to fourth decade of life and malignant lesions most commonly 
occurred in the seventh decade of life (37.5%). 
  
  
AGE WISE DISTRIBUTION
TABLE -4 : Total no of cases and percentage according to age group
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CHART 2 : No of thyroid lesions in different 
 Age  
(in years)
0-9 
10-19 
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50-59 
60-69 
>70 
TOTAL 
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 OF THYROID LESIONS
20-29 30-39 40-49 50-59 60-69 >70
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80
62
34
22
11
20.7
26.7
20.7
11.3
7.3
3.6
Age Group
age group
 
 
 No : of cases 
 
  Percentage 
2 0.7 
27 9 
62 20.7 
80 26.7 
62 20.7 
34 11.3 
22 7.3 
11 3.6 
300 100 
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Percentage
  
GENDER DISTRIBUTION
Among the 300 cases who presented wi
study the majority of cases wer
of (5.7%) and the female : male ratio was 16.5: 1.
CLINICAL PRESENTATION
Out of the 300 cases who presented with thyroid swelling
of the patients presented with lateral neck swelling (79%)
rest of them presented as
depicted in CHART-4,
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 [ CHART- 3] 
th thyroid swelling 
e females (94.3%) and the males
 
 [CHART -4]  
 in this study
 of thyroid
 a midline swelling (21%) in thyroid which is 
 mentioned below. 
Female
5.7
94.3
Gender
3 : Percentage of thyroid lesions 
 
in this 
 comprised 
 
 most 
 whereas 
Male
Female
  
DURATION OF SWELLING
Out of 300 cases, who presented with thyroid
swelling was noted it was
in 56.3% of cases, 1- 10 years in 13.3%
Maximum number of 
year which is depicted in the CHART 
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CHART 4 : Location of thyroid swelling in 
53 
 [CHART -5] 
 swelling, 
 < 6 months in 29.3% of cases, 6 months to 1 year 
 cases and > 10 years in 1% of
cases presented with a duration of 6 months to one 
-5 mentioned below. 
Medial neck swelling
79
21
Axis Title
present study
 
 
the duration of 
 cases. 
Series1
  
RATE OF GROWTH
Out of 300 cases
it was noted that 95.3% of patients had gradual progression of disease
4.7% had a sudden progression of 
study presented with a
swelling. 
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CHART -5 : Percentage of different thyroid 
lesions with different duration
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 [CHART-6] 
 who presented with swelling of thyroid in this study
disease. Most of the individuals in this 
 history of gradual onset of increase
6 Months to 
1yr
1-10 Yr More than 
10Yr
56.4
13.3
1
Duration of swelling 
 
 
 
 and 
 in size of the 
Percentage
  
CLINICAL SYMPTOMS
Out of the total 300 cases who
this study, it was noted 
dysphagia in 26.39% 
hoarseness of voice in 3% of patients
rest of the patients presente
individuals who presented in this
CHART 
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 [CHART -7] 
 presented with the thyroid swellings
that the most common clinical symptoms was
of patients followed by dyspnoea in 3%
 and pain in 3.3% of patients
d with no significant complaints.
 study had no significant complaints.
95%
5%
-6 : Percentage of thyroid lesions 
showing rate of growth
 
 
 in 
 
 of cases, 
 and the 
 Most of the 
 
Gradual
Sudden
  
FUNCTIONAL STATUS OF THE THYROID SWELLING
Out of the total
euthyroid. 
 I.HYPOTHYROID FEATURES
Out of 300 cases
hypothyroidism like bradycardia
 II.HYPERTHYROID FEATURES
Out of the total 300 cases
hyperthyroidism which were tachycardia
III. EUTHYROID  
Out of the total 300 cases
significant complaints.
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CHART- 7 : Percentage of clinical features in 
thyroid lesions in present study
56 
 300 cases studied, majority of the patients
 
, 12.3% cases presented with features of 
 and dry skin. 
 
, 1.7% cases presented with
 and moist skin. 
, 86% cases were euthyroid and had no 
 
Dysphagia Hoarseness Pain
36.30%
3% 3.30%
Series1
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 were 
 features of 
  
HORMONAL LEVEL ESTIMATION
T3, T4 and TSH LEVELS
Among the 37 patients who presented with features of hypothyroidism
clinically 35 cases (94.6%)
levels. These patients presented with
like bradycardia and dry
Among the 5 patients
clinically, 4 cases (80%) had
decreased TSH levels
symptoms of hyperthyroidism
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CHART 8: Percentage of functional status of 
thyroid lesions in present study
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 had decreased T3, T4 levels and 
 clinical symptoms of hypothyroidism
 skin.  
 who presented with features of hyperthyroidism
 increased T3 and T4 levels and a
 and all of these patients presented with
 like tachycardia and moist skin
Hyperthroid Euthyroid
1.7
86
Thyroid Status
 
 
 
increase in TSH 
 
 
ll of them had 
 clinical 
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Majority of the individuals
study were euthyroid 
hormonal levels were in the normal range
NATURE OF THYROID SWELLING
Of the total 300
study, 191 cases (63.7%
109 cases (36.3%) presented
191 cases of nodular swelling 
cases (16.8%) presented with multiple nodules. 
presented with a nodular swellin
in nature. 
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 who presented with thyroid swelling in our 
and as such had no significant complaints
.  
 [CHART-9] 
 cases who presented with thyroid swelling
) presented with features of nodular swelling
 with features of diffuse swelling
159 cases (83.2%) had solitary nodule
Majority of the patients 
g of thyroid and which was
Diffuse Swelling
63.7
36.3
Nature of swelling
-9 : Percentage of patients with 
 
 and their 
 in our 
, and 
 and out of the 
 and 32 
 mostly solitary 
 
Series1
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CORRELATION OF MICROSCOPING FINDINGS WITH NATURE 
OF THYROID SWELLING 
Of the total 300 cases who presented with thyroid swelling in this 
study , 159 cases (53%) presented with solitary nodule, 32 cases (10.7%) 
presented with multiple nodules, and the remaining 109 cases (36.3%) 
presented with diffuse swelling of thyroid. 
SOLITARY NODULE – 159 (53%) [CHART-10] 
Cystic lesion  - 3  
Benign  - 140  
Follicular neoplasm  - 9  
Papillary carcinoma  - 7   
MULTIPLE NODULE - 32 (10.6%) [CHART -11] 
Benign  - 28 
Follicular neoplasm     - 3  
Neoplastic         -  1 
Cystic          - 0 
DIFFUSE SWELLING  - 109(36.3%) 
Benign          -  40  
Hashimoto’s thyroiditis -  69 
Of the total 300 cases, the cystic lesion was present in 3 cases and all 
of them presented as solitary nodules,the benign lesion was reported in 277 
cases.Out of the 300 cases 159 cases presented as solitary nodules and out of 
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the 159 cases 140 cases (88%) were reported as benign,9cases(5.7%) 
reported as follicular neoplasm,7cases(4.4%) were reported as malignant and 
3 cases (1.9%) were reported as cystic lesion. Out of the 300 cases 32 cases 
presented as multiple nodules and out of the 32 cases benign lesion was 
reported in 28 cases (87.5%),3cases (9.3%) were reported as follicular 
neoplasm and 1 case(3.1%) was reported as malignant.Out of the 300 
cases,109 cases presented as diffuse swelling. Out of the 300 cases follicular 
neoplasm was reported in 12 cases out of which 9 cases (75%) presented as 
solitary nodules 3 cases (25%) presented with multiple nodules. Out of the 
total 300 cases 8 cases of papillary carcinoma diagnosed in this study, 7 
cases(87. 5% ) presented as solitary nodules and one case (12.5%) presented 
as multinodular swelling. 
TABLE-5: Correlation of microscopic findings with nature of the thyroid 
swelling 
Nature of 
swelling 
Cyst Benign Follicular 
Neoplasm 
Papillary Total 
Solitary 
nodule 
3 140 9 7 159 
Multiple 
nodule 
0 28 3 1 32 
Diffuse 
swelling 
0 109 0 0 109 
Column 
totals 
3 277 12 8 
300 
 
  
 
The TABLE-5 shows the correlation of the microscopic findings with 
the nature of the thyroid swelling.It was noted that out of the 300 cases 
maximum cases 277 (92.3%) 
300 were reported as follicular neoplasm, 3cases (1%) out of 300 were 
reported as cystic lesion and 8 cases(2.7%) out of 300 were reported as 
malignant. Out of the 277 cases reported as benign, maximum cases,140 
cases(50.5%) presented as solitary nodules
multiple nodules and 109 cases (39.3%) presented as a diffuse swelling of 
thyroid. 
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were reported as benign,12 cases (4%) out of 
,28 cases (10.1%) presented as 
Malignant Cystic lesion
9 7 3
solitary nodule
 
 
Benign
Follicular neoplasm
Malignant
Cystic lesion
  
The CHART -10
with solitary nodules and categorized in different microscopic criteria. Out 
of the total 300 cases 159 cases
159 cases 3 cases (1.9%)
Benign lesions, Follicular neoplasm reported in 9 cases
carcinoma in 7 cases (4.4%)
The CHART -11
with multiple nodules
multiple nodules. Out 
lesion was reported in 28 cases
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 shows the percentage of thyroid lesions presented 
 (53%) presented with solitary nodules
 diagnosed as cystic lesion, 140 cases
 (5.7%)
. 
 shows the percentage of thyroid lesions presented 
. Out of the total 300 cases,32 cases
of the 32 cases presented as multiple nodules
 (87.5%), Follicular neoplasm in 3 cases
Follicular neoplasm Malignant
3
1
11 : Thyroid lesions presenting as 
multiple nodules
Benign Follicular neoplasm Malignant
 
.Out of 
 (88%) as 
 and Papillary 
 
 presented as 
 benign 
 
  
(9.4%) and Papillary carcinoma in 1 case
cystic lesion. 
NATURE OF SWEL
 [CHART-12] 
Out of the total 300 cases
this study, 90 patients were diagnosed as Hashimoto’s thyroiditis and out of 
the 90 cases 69 cases presented with
remaining 21 cases presented
  In this study 
thyroiditis presented with a diffuse swelling of thyroid
presented with a nodular swelling of thyroid
 
CHART- 12 :Percentage of nodular and diffuse 
lesions in Hashimoto’s thyroiditis.
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 (3.1%) and no case presented with 
LING IN HASHIMOTO’S THYROIDITIS
, who presented with a thyroid swelling in 
 a diffuse swelling in 
 with a nodular swelling. 
most of the patients (76.7 %) with Hashimoto’s 
 and (
. 
 
Diffuse
77%
Nodular
23%
 
 
thyroid and the 
23.3%) of cases 
 
  
SIZE OF THE SWELLING
Of the total 300 cases
study, the size of the 
swelling were more than 1 cm
our study, 18 cases (6%) presented with a thyroid swelling of
and the rest 282 cases 
cm. All the thyroid swelling
were reported as benign
 
 
 
CHART- 13 : Percentage of size of swelling < 
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 [CHART -13] 
 who presented with thyroid swelling in our 
thyroid swelling was noted. Majority of the thyroid 
. Out of the total 300 cases who presented in 
(94%) presented with thyroid swelling of more than 1 
 which were of size of less than 1cm
 lesion in thyroid. 
6%
94%
or > 1 cm.
 
 less than 1 cm 
, all of them 
 
  
CONSISTENCY OF THE SWELLING
Of the total 300 cases
swelling was firm in consistency in 65.3% of patients
28.3% of patients and cystic consistency in 4.3% of patients and hard in 
consistency in 2.1% of patients
MOVEMENT WITH DEGLUTITION
 Of the total 300 cases
the swellings moved with deglution
) of patients it did not moved with deglutition.
 
66%
CHART- 14 : Percentage of patients showing 
various consistency of the swelling
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 [CHART -14] 
 who presented with thyroid swelling
, soft in consistency in 
.  
 
 presented with thyroid swelling in our study
 292 (97.3%) of patients 
 
28%
4%
2%
Consistency of the swelling
Soft
Cystic
Firm
Hard
 
 the 
 
 most of 
except in (2.7% 
  
NATURE OF THE THYROID
Of the total 300 cases
was done in all 300 cases of which 
aspirate and the rest of the cases 229 
Majority of follicular neoplasm
presented with a haemorrhagic aspirate
 
 
 
76%
CHART- 15: Percentage of patients showing 
different nature of aspirate
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 ASPIRATE [CHART- 15]
 presented with thyroid swelling
71 cases (23.7% ) had a
(76.3%) had a haemorrhagic aspirate.
 (91.7%) and all the malignant lesions
. 
24%
 
 
, the aspiration 
 brown color 
  
 
 
Nature of aspirate
Brown
Haemorrhage
  
ANALYSIS OF THE ASPIRATE
The analysis of aspirate from all 300 thyroid swelling
aspirate was compared with the microscopic nature of the swelling and 
categorized as mentioned in CHART
BROWN COLOURED 
Cystic lesion 
Benign  
Thyroiditis   
Malignant  
The CHART-16 shows the
colored aspirate.Out of the 300 cases 71 cases(23.7%) presented with a 
brown color aspirate and out of the 71 cases 
benign in 57 cases(80.3%)
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 was done
-16 and CHART-17. 
– 71 (23.7% )[CHART -16] 
-  3 
-  57 
-  10 
-  1 
 thyroid lesions that showed a brown 
the aspirate was reported as 
, 10 cases (14.1%) were reported as thyroiditis, 
Thyroiditis Cystic lesion Malignant
10
3
Brown colored aspirate
brown colored aspirate
 
 and the 
 
1
  
3cases (4.2%) were reported as cystic lesion
malignant. 
HAEMORRHAGIC 
Cystic lesion  - 0 
Benign - 142 
Thyroiditis - 80 
Malignant - 7 
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CHART -17 : No : of thyroid lesions showing 
68 
,1case (1.4%) was reported as 
ASPIRATE -229 (76.3% )[CHART-17]
 
 
Thyroiditis Malignant
80
7
Haemorrhagic aspirate
haemorrhagic aspirate
 
 
 
  
The CHART-17
haemorrhagic aspirate.
a heamorrhagic aspirate and out of the 229 cases 
benign in 142 cases
thyroiditis,7cases (3%)
TYPE OF SMEAR [CHART 
Of the total 300 cases
was directly made in 238 cases (79.3%) and it was a centrifuged smear in 
20.7% of cases. 
 
CHART- 18 : Percentage of type of smear in 
69 
 shows the thyroid lesions that showed a 
Out of the 300 cases 229 cases(76.3%) presented with 
the aspirate was reported as 
(62%), 80 cases (35%) were reported as 
 was reported as malignant. 
-18] 
 who presented with thyroid swelling
 
79.30%
20.70%
thyroid lesions
 
 the smear 
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CELLULARITY OF THE SMEAR [CHART- 19] 
Of the total 300 cases the aspirations were sparse in cellularity in 26 
cases (8.7%), moderate cellularity in 247 cases (82.3% ) and marked 
cellularity in 27 cases (9%). Out of the total aspirations the background of 
the smear showed colloid in 19% of cases and haemorrhage in 66.3% of 
cases and inflammatory background in 14.7% of cases. 
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showing different cellularity
Series1
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CYTOLOGICAL DIAGNOSES IN THYROID LESIONS BY 
CONVENTIONAL METHOD [TABLE – 6], [CHART- 20],[CHART-
21] 
Out of the total 300 cases, 292 cases were diagnosed as benign by 
conventional cytological method and 8 cases were reported as malignant by 
the conventional method. Of the total aspirations diagnosed as benign,the 
colloid nodule was reported in 52 cases(17.3%), Nodular goiter in 108 cases 
 (36%), Adenomatous goiter in 23 cases (7.7%), Hashimoto thyroiditis in 90 
cases (30%), Follicular neoplasm in 12 cases (4%), Caseating granulomatous 
inflammatory pathology in 1 case (0.3%), cystic lesion of thyroid in 3 cases 
(1%), follicular neoplasm / dominant nodule of nodular goiter in 3 cases 
(1%). Of the total aspirations diagnosed as malignant, all of them were 
reported as papillary carcinoma of thyroid. 
TABLE - 6: Cytologic diagnosis in thyroid lesions by conventional method. 
BENIGN LESIONS 
Colloid 
nodule 
Nodular 
goiter 
Adenomatous
goiter 
Hashimoto 
thyroiditis 
Follicular 
neoplasm 
Cystic 
lesion of 
thyroid 
FN/DN Of 
nodular 
goitre 
Granulomat
ous 
thyroiditis 
52 
(17.3%) 
108(36%) 23(7.7%) 90(30%) 12(4%) 3(1%) 3(1%) 1(0.3%) 
 
MALIGNANT 
Papillary carcinoma – 8(2.7%) 
 
  
CYTOLOGICAL DIAGNOSIS
The CHART- 20
by conventional cytology a large number of cases were reported as nodular 
goitre,followed by Hashimoto’s and colloid nodule
CYTOLOGICAL DIAGNOSES
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 [CHART-20] 
 and CHART – 21 shows out of 300 cases diagnosed 
. 
 AS PER PERCENTAGE [CHART
108
23
90
12 3 3 1
conventional cytology
17%
36%
3%
conventional cytology
Colloid nodule
Nodular goiter
Adenomatous goitre
Hashimotothyroiditis
Follicular neoplasm
Cystic lesion of thyroid
FN/DN of nodular goitre
Granulomatous thyroiditis
Malignant
 
 
-21] 
 
8
  
73 
 
AGE WISE DISTRIBUTION OF THYROID LESIONS ACCORDING 
TO CONVENTIONAL CYTOLOGICAL METHOD [TABLE-
7],[CHART-22] 
TABLE- 7 : Age distribution of different thyroid lesions in present study 
according to conventional cytology. 
Age 
(in years) 
Benign Follicular 
neoplasm 
Malignant Total 
0-9 2 0 0 2 
10-19 25 1 1 27 
20-29 59 2 1 62 
30-39 78 1 1 80 
40-49 58 3 1 62 
50-59 32 2 0 34 
60-69 20 1 1 22 
>70 6 2 3 11 
TOTAL 280 12 8 300 
The TABLE- 7 shows the age distribution of various thyroid lesions 
according to the conventional cytological method. The highest number of 
cases occurred in the age group of 30-39 years and the cases were 
predominantly benign reported under this age group. The maximum number 
of cases in the category of follicular neoplasm presented in middle age. The 
  
lesions classified as malignant most commonly presented in seventh d
of life.[CHART-22] 
AGE WISE DISTRIBUTION OF THYROID LESIONS ACCORDING 
TO CONVENTIONAL METHOD
CHART 22 : Age wise distribution of
conventional method 
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 thyroid lesions according to 
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CYTOLOGICAL DIAGNOSIS BY BETHESDA CLASSIFICATION 
CATEGORY I (NON DIAGNOSTIC ) : 
Out of 300 patients, 3 cases (1%) the aspirates were unsatisfactory and 
were diagnosed under nondiagnostic or unsatisfactory category. 
CATEGORY II (BENIGN) :  
This category included most of the cases in the study with 274 cases 
(91.3%) out of the total 300 cases. It consists of non- neoplastic or negative 
for malignancy cases like colloid goitre with 52 cases (17.3% ), adenomatoid 
nodule 131 cases (43.7% ), granulomatous  
(subacute ) thyroiditis 1 case (0.3%), hashimoto’s thyroiditis 90 cases (30%). 
 CATEGORY III (AUS/FLUS) : 
 This category includes lesions which were not either clearly benign or 
malignant. The conclusive opinion is difficult in this category. we had 1 case 
(0.3%) under this category. 
CATEGORY IV(FN/ SFN) : 
 Under this category we had 12 cases (4%) of the total 300 cases 
reported as follicular neoplasm. 
CATEGORY V (SFM) :   
This category includes 2 cases (0.7%) out of the total 300 cases in our 
study. 
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CATEGORY VI (Malignant) :  
This category includes 8 cases (2.7% ) out of the total 300 cases in our 
study and all of them comprising of papillary carcinoma thyroid. 
PERCENTAGE OF DIFFERENT CATEGORIES OF THYROID 
LESIONS ACCORDING TO BETHESDA [TABLE-7] 
BETHESDA CATEGORY 
TABLE- 8 : Classification of thyroid lesions in Bethesda system. 
BETHESDA CATEGORY 
NO: OF  
CASES 
PERCENTAGE 
CAT I : NON DIAGNOSTIC 3 1 
CAT II: BENIGN 274 91.3 
CAT III: AUS / FLUS 1 0.3 
CAT IV: FN/SFN 12 4 
CAT V : SFM 2 0.7 
CAT VI : MALIGNANT 8 2.7 
   TOTAL 300 100 
 
Out of the total 300 thyroid cases presented in our study, by 
classifying lesions in conventional cytological classification 292 cases were 
diagnosed under benign category and the remaining 8 cases were diagnosed 
as malignant, by classifying the lesions in Bethesda out of the total 292 cases 
  
diagnosed under benign category by conventional cytology
classified in Non – diagnostic category
of Atypia of undetermined significance / follicular lesion of undetermined 
significance, 2 cases were classified
malignancy, 12 cases were classified under the category of Follicular 
neoplasm/ Suspicious for follicular neoplasm
classified in the category of Benign 
8 cases were seen.[TABLE
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AGE GROUP ACCORDING TO BETHESDA CLASSIFICATION 
[TABLE-9],[CHART-24] 
Table 9 : No : of cases in Bethesda category according to age group 
AGE IN 
YRS 
CATI CAT II CATII
I 
CAT IV CAT V CAT VI 
0- 9 0 2 0 0 0 0 
10 – 19 
 
1 26 0 1 0 1 
20- 29 1 57 0 2 0 1 
30- 39 0 76 1 1 0 2 
40 - 49 0 53 0 3 1 1 
50 – 59 0 32 0 2 1 0 
60- 69 1 21 0 1 0 0 
>70 0 7 0 2 0 3 
TOTAL 3 274 1 12 2 8 
 
The above table shows the number of cases in different age group 
according to Bethesda. In all age groups the maximum number of cases were 
present in Category II. In 0-9 yr age group 2 cases were present and both 
were diagnosed under Category II. Category I showed 3 cases in the age 
group ranging from 10-69 years. There was 1 case diagnosed in Category III 
in the age group of 30-39 years. In Category IV cases were present in all age 
  
groups except in 0-9 yrs age 
of 40-59 years. In Category VI there were cases in all age group except 0
9yrs and 40-59 years and maximum number of cases were seen after the 
seventh decade of life in this category
NO OF CASES ACCORDING T
GROUP [CHART-24]
 
CHART- 24 : No : of cases according to age group in Bethesda category
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GENDER WISE DISTRIBUTION ACCORDING TO BETHESEDA 
CLASSIFICATION [TABLE
TABLE- 10 : Gender wise 
GENDER CAT   
I 
MALE 1 
FEMALE 2 
 
The TABLE-10
distributed according to gender in each category of the Bethesda system.
maximum number of cases were present in Category II
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distribution according to Bethesda category
CAT 
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CAT     
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 and CHART-25 shows the number of cases 
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female population. In Category I average number of cases were present in 
both genders. In Category III, IV and V, cases were present in female 
population while the male population had no cases. In Category VI the 
highest number of cases were present in female population compared to 
males. 
GENDER WISE (MALE) DISTRIBUTION ACCORDING TO AGE 
GROUP BY BETHSEDA [TABLE-11], [CHART-26] 
TABLE -11 : Gender wise (male) distribution in Bethesda in age group 
Age in 
Years 
Gender 
Male 
CAT 
I 
CAT II CAT 
III 
CAT 
IV 
CAT V CAT 
VI 
0-9 0 0 0 0 0 0 0 
10-19 2 1 1 0 0 0 0 
20- 29 4 0 3 0 0 0 1 
30-39 3 0 3 0 0 0 0 
40-49 6 0 6 0 0 0 0 
50-59 1 0 1 0 0 0 0 
60-69 1 0 1 0 0 0 0 
>70 0 0 0 0 0 0 0 
 
The TABLE-11 and the CHART-26 shows the number of cases 
according to age group in male population in the present study according to 
Bethesda classification. There were no case in the 0-9 yr age group in all 
  
Categories. In 10-19 yr age group cases were present in Category I and 
Category II. The 20-29 yr age group had
VI. In 30-39,40-49,50
Category II. In the age group > 70 years had
Categories. 
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GENDER WISE DISTRIBUTION (FEMALE ) IN AGE GROUP BY 
BETHESDA [TABLE-12], [CHART -27] 
TABLE- 12 : Gender wise distribution (female) in Bethesda according to 
age group  
AGE IN 
YEARS 
GENDER 
FEMALE 
CAT I 
ND 
CAT II 
BENIGN 
CAT 
III 
AUS 
CAT IV 
FN/SFN 
CATV 
SFM 
CAT 
Malignant 
0-9 2 0 2 0 0 0 0 
10-19 27 0 25 0 1 0 1 
20- 29 57 1 54 0 2 0 0 
30-39 77 0 73 1 1 0 2 
40-49 52 0 47 0 3 1 1 
50-59 34 0 31 0 2 1 0 
60-69 22 1 20 0 1 0 0 
>70 12 0 7 0 2 0 3 
 
The TABLE-12 and the CHART-27 shows the number of cases in each age 
group according to Bethesda classification in the present study in the female 
population. The Category II had the highest number of cases compared to all 
other categories in all age groups.In 0-9 yrs age group cases were present 
only in Category II. In 10-19 yrs age group cases were present in Category 
II, IV and VI. In 20-29 yrs age group cases were present in Category I,II and 
IV. In 30-39 year age group cases were present in Category II, III,IV. In the 
  
age group of 40-49 years
59 year age group cases were present in Category II, I
years age group cases were present in Category I, II,and IV. In the age group 
of above 70 years cases were present in Category
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CYTOLOGICAL FEATURES OF BENIGN NODULES 
Among the 274 cases (91.3%) reported as benign under betheseda 
category, 52 cases (17.3%) had cytological features consistent with colloid 
nodule and 131 cases (43.7%) had cytological feature consistent with 
adenomatoid nodule, 90 cases(30%) had cytological features consistent with 
hashimoto,s thyroiditis. 
Of the 52 cases reported as colloid goitre all the 50 cases (96.1%) had 
benign thyroid follicular cells arranged predominantly in clusters and sheets 
in 2cases. The background colloid quality was thin in majority of cases. The 
amount of colloid in background was of moderate amount in majority of the 
cases and abundant amount in some cases. Some cases showed lymphocytes, 
macrophages also in the background of the smear diagnosed as colloid 
nodule. The thyroid follicular epithelial cells were of normal size in all 
clusters with no pleomorphism.  
Of the 90 cases (30%) that are reported as “consistent with 
lymphocytic (Hashimoto) thyroiditis in a proper clinical context”, all of them 
had Hurthle cells changes in the follicular cells and the Hurthle cells were 
predominantly seen in clusters and in few smears the Hurthle cells were seen 
arranged in sheets. Lymphocytic background was seen predominantly in all 
cases of Hashimoto’s thyroiditis and few cases showed macrophages.  
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CYTOLOGICAL FEATURES OF PAPILLARY CARCINOMA 
Out of the total 300 cases, 12 cases that were reported as papillary 
carcinoma according to bethesda, and all the 12 cases had marked cellularity 
and papillary fragments seen in 100 % of cases with individual cells showing 
oval shaped cells (75%), and plemorphism in few cells. The individual cells 
showed moderate amount of eosinophilic cytoplasm(100%). 
The nucleus was oval (75%) to round (25%) in shape, ground glass 
appearance (100%) with powdery chromatin (100%), nuclear grooves 
(100%), nuclear inclusions (100%) and prominent nucleoli. Hurthle cell 
changes were noted in (100 % ) of cases. Background showed lymphocytes 
and haemorrhage in (100% ) of cases. Psammoma bodies were not seen in 
any of these cases. 
CYTOLOGICAL FEATURES OF FOLLICULAR NEOPLASM 
Of the 12 cases (4%) cytologically reported as follicular neoplasm 
according to betheseda classification, 9 cases (75% ) had marked cellularity 
and 3 cases (25%) had moderate cellularity. The cytological features include 
microfollicles in (100%) of cases and cell clusters in (100%) of cases. 
Individual cells were uniform in 100% of cases, round (76.9%) to oval 
(23.1% ) with moderate amount of cytoplasm in (100%) of cases and the 
cytoplasm is eosinophilic in (91.7%) of cases and basophilic cytoplasm in 
(8.3%) of cases. The nucleus were round in shape in (83.3%) of cases and 
oval in shape in (16.7%) of cases and exhibiting nuclear hyperchromatism in 
(66.7%) of cases. Background showed haemorrhage in (83.3% ) of cases and 
colloid in moderate amount (16.7%) of cases.  
  
                                  
 
 
 
 
 
 
Figure -1 
Nondiagnostic.  Cystic  macrophages  are seen in sheets H&E , 100x 
 
                                      
 
 
 
 
 
 
 
 
Figure -2 
Nondiagnostic .Cystic  macrophages with abundant cytoplasm  and  contains  
hemosiderin  pigment, H&E  , 400x 
 
  
 
                                             
 
 
 
 
 
 
Figure -3 
Benign follicular nodule. Nuclear overlapping in the form of folded 
Sheets   is  observed  . Watery colloid is present in the background , H&E,. 
400x 
 
 
 
 
 
 
 
 
 
 
 
 
Figure -4Benign follicular nodule(Nodular goitre). Benign follicular cells  
arranged in clusters   and   have round to oval  nuclei with finely granular 
chromatin and inconspicuous nucleoli , H& E , 400x 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-5 
Benign follicular nodule(Adenomatoid nodule). Monolayered sheets of 
follicular cells ,  moderate amount of pale cytoplasm , monomorphic nuclei , 
inconspicuous nucleoli, H&E stain , 400x 
 
 
Figure -6 
Lymphocytic (Hashimoto’s) thyroiditis. There is a mixed population 
of Hürthle cells and polymorphic lymphocytes , H&E stain , 100x view 
 
 
 
                                           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure -7 
Lymphocytic (Hashimoto’s) thyroiditis. There is a mixed population 
of Hürthle cells and polymorphic lymphocytes , H&E  , 400x view 
 
 
 
 
 
 
 
 
 
 
                                           
 
 
 
 
 
 
 
Figure -8 
Granulomatous (subacute) thyroiditis. Epithelioid  cells in sheets 
mixed inflammatory cells, and benign follicular cells are present , H&E , 
400x 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure - 9 
AUS : Sheets of thyroid follicular cells , in diffuse sheets and some in microfollicle 
pattern , with mild  nuclear and cytoplasmic enlargement , some of the nuclei 
showing nuclear inclusion ,H&E stain ,400x 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure -10 
Follicular neoplasm/Suspicious for a follicular neoplasm. Folliculacells are 
arranged as microfollicles   having monomorphic nuclei  and moderate 
cytoplasm , H& E  ,100x 
 
 
 
                                               
 
 
 
 
 
 
 
 
 
 
 
Figure -11 
Follicular neoplasm/Suspicious for a follicular neoplasm. Follicular 
cells are arranged as microfollicles and have round nuclei, H&E stain , 400x 
 
                                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure -12 
Follicular neoplasm/Suspicious for a follicular neoplasm. 
Follicular cells in crowded, microfollicular arrangements show slight size 
variation in nuclear  size  ,inconspicuous  nucleoli . H&E stain , 400x 
 
 
 
                                          
 
 
 
 
 
 
 
 
 
 
 
 
Figure -13 
Suspicious for papillary thyroid carcinoma.  The  follicular cells arranged in 
papillary pattern, nuclear enlargement ,nuclear crowding,H&E ,100x 
 
                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure -14 
Suspicious for papillary thyroid carcinoma: Follicular cells are arranged in 
papillae,with few nucleus showing nuclear grooves and nuclear 
pseudoinclusion, H&E, 100x 
 
 
 
 
                                           
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure -15 
Papillary thyroid carcinoma: Follicular cells are arranged in papillae, marked 
crowding of the neoplastic cells that line the papillae,H&E,100x 
 
 
 
                                              
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure -16 
Papillary thyroid carcinoma : Thyroid  follicular epithelial cells arranged  in 
monolayered  sheets forming anatomical border,H&E , 100x 
 
 
 
 
 
 
                                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure- 17 
Papillary thyroid carcinoma: Papilla with fibrovascular core,H&E,400x 
 
 
 
Figure -18Papillary thyroid carcinoma: Follicular cells showing nuclear 
crowding, nuclear grooving,nuclear molding,H&E, 400x 
 
 
 
Figure- 19 
Papillary thyroid carcinoma. Thyroid follicular cells in clusters , finely 
textured (powdery) chromatin, H&E,400x 
 
 
 
 
 
 
                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure -20 
Papillary thyroid carcinoma: There is marked crowding of the neoplastic 
cells , nucleus showing powdery chromatin,H&E, 400x 
 
 
 
                                    
 
 
 
 
 
 
 
 
 
 
 
Figure -21 
Papillary thyroid carcinoma showing Multinuleated giant cell ,H&E,400x 
 
 
 
                                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure- 22 
Papillary  thyroid  carcinoma:Follicular cells arranged in sheets ,few nuclei 
showing nuclear pseudoinclusion and  nuclear grooving,H&E,400x 
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DISCUSSION     
FNAC is the gold standard and the primary investigation of choice in 
the management of thyroid lesions along with the other investigations like 
ultrasonography (USG) examination, the thyroid function tests, thyroid scan, 
and the thyroid antibody levels are subsequently done to find out patients 
who require surgery and those who can be managed conservatively.[88]The 
reporting of the thyroid FNA suffers from the usage of “personalized”, local, 
institutional and descriptive terminologies. The ultimate goal of performing 
FNAC in the patients presenting with thyroid nodules is to diagnose the 
lesion as benign or malignant. The patients presenting with cytologic 
diagnosis suggestive of malignancy and/or neoplasia are treated surgically, 
while the patients presenting with the cytologic diagnoses of benign lesion 
can be followed up clinically. 
The diagnosis of thyroid FNA differs from one institution to another 
institution. This difference is due to several factors, which include,  
a) The method by which the lesional tissue of thyroid is obtained by 
FNA, whether it is performed under ultrasound guidance or not, and 
also depends upon the experience in smearing and preparation of the 
cytology slides, 
b) the experience of the cytology technologists, 
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c) The interpretation in case of cytologic material, particularly in lesions 
such as uncertain categories which include the follicular lesions, iv) 
and finally the reporting method of the thyroid FNA results. 
Being a tertiary care hospital we receive many patients of thyroid 
disorders from the nearby districts. The majority of the lesions are usually 
benign and they require no aggressive treatment. The interpretation in each 
and every case is very crucial for further management Also we wanted to 
have an uniform communication between the pathologist, radiologist, 
endocrinologist, surgeons and the treating physicians. So that there would be 
no confusion regarding the management of every patients. 
To achieve the standardization in the reporting of thyroid FNA, the 
National Cancer Institute (NCI) hosted the ‘NCI Thyroid Fine Needel 
Aspiration State of the Science Conference’ which gave rise to the 
information of ‘The Bethesda System for Reporting Thyroid Cytopathology’ 
(TBSRTC) [89,90]. TBSRTC is a vital classification as it bridges the 
communication gap and is useful to maintain uniformity in the reporting of 
thyroid lesions. We followed the TBSRTC guidelines and each and every 
case was classified according to the six tier reporting guideline from 
category I to VI according to the Bethesda classification. 
The use of these well-defined criteria for adequacy in thyroid FNA 
samples is helpful as they improve the diagnostic efficiency of thyroid FNA 
and also avoid the unnecessary surgery for benign and non neoplastic thyroid 
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lesions. The lesional characteristics of the thyroid gland and other than cystic 
features which cause sampling error are with the thyroid gland which 
presents with multiple nodules, calcification and fibrosis. The sample 
adequacy of the FNA thyroid may be affected by the structure of lesion and 
the needle localization ‘ the geographic miss of the needle’, the method of 
guidance, the number of aspirated samples, the needle gauge, the aspiration 
technique, and the presence or absence of on-site facilities for immediate 
cytologic examination. 
The category of the ND/UNS cytologic findings may also result from 
factors such as poor preparation of the smear, poor fixation of the smear or 
poor staining or from the prescence of excessive blood, prescence of necrotic 
material, or debris obscuring cellular details, and also misinterpretations. 
However it is, important to keep in mind that ND/UNS specimen does not 
always mean as a negative specimen. An experienced cytopathologist, can do 
an accurate localization of the lesion either by palpation or by ultrasound, 
and by performing between 1-5 aspirates for thyroid nodules of 1-2 cms size 
with 20-27 gauge needles, using standard sampling technique, supported by 
immediate on-site cytological analysis can ensure specimen adequacy. The 
nodules which are reported as ND/UNS result should be re-aspirated, but no 
sooner than 3 months later; the 3-month interval is recommended so as to 
prevent the false positive interpretations due to reactive/reparative changes. 
The categories that require repeat FNA include the sample inadequacy, 
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nodule enlargement, cyst recurrence, or clinical or imaging findings that 
arouse a suspicion of a malignancy even when the cytological findings in the 
biopsy specimen indicate benignity. The thyroid FNA with an ultra sound 
guidance is preferred for a repeat aspiration in the case where an ND/UNS 
report has been given, and especially for solid nodules. The repeating of 
thyroid FNA results in a diagnostic interpretation in up to 60% of cases. 
Several studies have shown that the ultrasound guided FNAs of thyroid have 
shown to reduce the rates of non-diagnostic (i.e., insufficient cells and/or 
colloid) and the false negative aspirates. 
A simplified reporting scheme would, undoubtedly, have to address 
the assessment of adequacy and an acceptable rate of inadequate diagnoses 
could then be determined [91]. 
The reporting of thyroid cytology classification by using Bethesda 
System is a standardized reporting and it classifies the thyroid fine-needle 
aspiration reports into 6 diagnostic categories which have a unique risks of 
malignancy and have specific recommendations for clinical management. 
The categories include (I) Nondiagnostic (II) Benign (III) Atypia of 
undetermined significance /follicular lesion of undetermined significance 
(IV) Follicular neoplasm/suspicious for a follicular neoplasm (V) 
Suspiciously for malignancy and (VI) Malignant aspirates.[92,93,94] By using 
the Bethesda reporting system it helps in the better prognosis, management 
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as well as patient’s outcome and it also minimizes the unwanted surgical 
procedures for thyroid swellings.[95] 
The fine needle which was used in present study had a gauge of 23 
and was found to yield good cellular smears.The length of the needle 
favoured was one and a half inches and in the present study the same was 
found to be of optimal length and reached all the areas in a thyroid nodule. 
10 ml or 20 ml syringes were employed by most operators. Walfish et 
al.(1977) used 10 ml syringe fitted with an 18 gauge needle for cystic 
lesions. Thomas A Colacchio et al. (1980) used 5 ml syringe. 1 ml of 
tuberculin syringe with a 1.5 cm long 25 gauge needle mounted on it was 
employed by Norton LW et al..(1982)...In our series a 5ml of disposable 
syringe was used and 10 ml of syringe used occasionally when the cystic 
fluid was aspirated.  
All the authors used disposable needles including in the present study 
as they are least traumatic, less painful and perfectly sterile. A local 
anaesthetic was infiltrated into the skin to avoid pain to the patient by 
Colacchio TA et al. (1980), Norton W et al. (1982) and Rosen IB et 
al.(1981). None of the patients complained of significant pain in the present 
study. Local anaesthesia was not required according to the present study, 
when a fine and disposable needle (22- 24) gauge is used. [96] [97] 
There were 3 unsatisfactory aspirations out of total 300 cases. They 
contained only haemorrhage and thin cystic fluid in the background admixed 
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with predominantly cyst macrophages and a very few scattered thyroid 
follicular epithelial cells. 
SATISFACTORY SMEARS [TABLE -13] 
In our study of 300 cases, 297 aspirations were satisfactory and 3 
aspirations were unsatisfactory as it contained only haemorrhage and thin 
cystic fluid in the background admixed with predominantly cyst 
macrophages  and few inflammatory cells. 
 TABLE- 13: Percentage of satisfactory smears from different series 
SI 
NO 
 
Name of the Author 
 
year 
Number of 
Aspirations 
Adequate 
Material 
 
Percenta
ge 
1 Walfish et al.[101] 1977 88 83 94.3% 
2 Frable and Frable[102] 1979 91 87 95.6% 
3 Rosen LB et al [103] 1980 153 144 94. 0% 
4 Al shayer HM et al[104] 1983 62 61 98.0 % 
5 Klemi PJ et al[105] 1990 1054 1007 95.5% 
6 Tabaqchali et al[106] 2000 302 210 70.02% 
7 Sclabas GM et al[107] 2003 240 225 93.02% 
8 Present study 2013 300 297 99 .0% 
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The above table shows the percentage and number of satisfactory 
aspirations in present study and in different series. Our study showed the 
highest number of satisfactory smears, followed by Al shayer HM et al. 
AGE DISTRIBUTION 
The age of the patients varied from 9 to 85 years with the mean age of 
38.3 years. The mean age group studied by Gershengorn et al (1977) was 39 
years.. Colacchio TA et al (1980) reported the age of their patients ranging 
between 30 – 60 years. The age of the patients studied by Bhagat VM et al 
(2014) ranged from 20 – 50 years, the age group ranged from from 5 years to 
70 years in this study. [98] The age of the patients studied by Silverman JF et 
al (1987) ranged from 16- 79 years. 
In the present study, patients in the third and fourth decades of life 
comprised 68 %. Age distribution of lesions in our study correlates well with 
the observation of Bhagat V M et al (2014) with 67 % of cases in the third 
and fourth decade and the study of Pandit AA and Kinare et al (1986) who 
reported 62% cases in third and fourth decade. 
GENDER DISTRIBUTION 
  The gender ratio (female : male ) in the present study was 16.5 : 1. 
The majority of cases were females mostly encountered in the young and 
middle age groups. In the series of Bhagat VM et al (2014) female to male 
ratio was 5.67:1.[90] Pandit AA and Kinare et al (1986) reported female : 
male ratio was 58:26., Klemi PJ et al (1990) series, female: male ratio was 
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8:1. Similar female predominance seen in studies conducted by 
Unnikrishnan et al (2011).[98] High frequency of women were observed in 
the present study which correlated with most of the other series. We had a 
similar observation. 
DISTRIBUTION OF LESIONS ACCORDING TO BETHESEDA 
CLASSIFICATION 
CATEGORY I - NON DIAGNOSTIC OR UNSATISFACTORY 
This category includes the cases in which the adequate material for 
reporting like six groups of well visualised thyroid follicular cells with at 
least minimum of ten cells per group is not present, or the prescence of cyst 
fluid only, or any obscuring elements like only macrophages or haemorrhage 
or any preparation artifact. In the present study out of the total 300 cases, 3 
cases (1%) were present in this category as these smears did not have the 
adequate thyroid clusters, there were only few scattered thyroid follicular 
cells, and the smears contained only haemorrhage,admixed with a cystic 
fluid and predominant sheets of cyst macrophages and few inflammatory 
cells. The percentage of cases under this category were very less when 
compared to other studies as mentioned in TABLE -14 .[99] 
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TABLE- 14 : Percentage of cases in Non – diagnostic category according 
to Bethesda in different series. 
S.NO SERIES NON-DIAGNOSTIC 
(%) 
1. Faquin WC in Krane J F et al (2011)[108] 13.9 
2 Kim SK et al (2011) [109] 1.8 
3. Nayar R in Ivanovic et al (2009) [110] 5.3 
4. Theoharis CG et al (2009)[111] 11.1 
5. VanderLaan PA et al (2011) [112] 12.5 
6. Marchevsky AM (2010) et al[113] 12.9 
7. Jo V Y et al (2010)[114] 18.6 
8. Renshaw AA et al (2010) [115] 23.6 
9. Present study 0.3 
  
The TABLE-14 shows the percentage of cases diagnosed in the Non- 
diagnostic category in the present study and in different series. In our present 
study the number of cases under this category were less compared to other 
series. Renshaw AA et al (2010) series showed a highest percentage of cases 
under this category followed by Faquin WC in Krane J F et al 
(2011),Marchevsky AM (2010) et al and VanderLaan PA et al (2011). Rest 
of the series showed a slight higher percentage of cases compared to our 
study.  
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CATEGORY II – BENIGN : 
The term benign follicular nodule is applied to most common benign 
pattern and the other subcategories under this benign lesions include 
hashimoto’s thyroiditis, granulomatous (subacute ) thyroiditis. 
 In the present study out of the 300 cases 274 cases (91.3%) were diagnosed 
as benign lesions by classifying them in the Bethesda classification.The most 
common benign conditions that constitutes the group includes 131 cases of 
adenomatous goitre (43.7%), and followed by 90 cases of Hashimoto’s 
thyroiditis, 52 cases of colloid rich nodule (17.3%) and a single case of 
granulomatous (subacute ) thyroiditis. 
We had a higher percentage of cases under the category when 
compared with the observation of other authors. When comparing various 
studies it shows that the cases diagnosed under the benign category of 
Bethesda comprises the bulk of thyroid lesions compared with the other 
diagnostic categories in the Bethesda system of classification. In the studies 
conducted by Unnikrishnan et al (2011), Bhagat VM et al (2014) had similar 
findings and 60-70% cases belonged to benign category.[99] The other studies 
done by various authors showed various percentages under this category 
which are mentioned in TABLE-15. 
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TABLE 15: Percentage of thyroid lesions in Benign category according to 
Bethesda in different series. 
S.NO SERIES BENIGN (%) 
1. Faquin WC in Krane J F et al (2011)[108] 66.9 
2. Kim SK et al (2011) [109]  58.3 
3. Nayar R in Ivanovic et al (2009) [110] 64.2 
4. Theoharis CG et al (2009)[111] 73.8 
5. VanderLaan PA et al (2011) [112] 62.7 
6. Marchevsky AM (2010) et al[113] 71.6 
7. Jo V Y et al (2010)[114] 59.0  
8. Renshaw AA et al (2010) [115] 54.0 
9. Present study 91.3 
 
The TABLE-15 shows the percentage of cases diagnosed under 
benign category in present study and in different series. Our study showed 
the highest percentage of cases diagnosed under this category followed by 
Marchevsky AM et al and the rest of the series had a similar distribution of 
cases under this category. 
CATEGORY III : ATYPIA OF UNDETERMINED SIGNIFICANCE 
OR FOLLICULAR LESION OF UNDETERMINED SIGNIFICANCE 
It includes the thyroid lesions that cannot be classified as benign, 
suspicious for malignancy or malignant lesions, an AUS result of (3- 6% ) is 
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obtained in a routine thyroid FNA, this category should be used very 
discriminately. In the present study 1 case (0.3%) was reported under this 
category. The other studies done by various authors showed various 
percentages under this category which are mentioned in TABLE-16. 
TABLE- 16: Percentage of cases in various studies in the AUS/FLUS category. 
S.NO SERIES AUS/ FLUS (%) 
1. Faquin WC in Krane JF et al (2011)[108] 10.0 
2. Kim SK et al(2011) [109] 16.3 
3. Nayar R in Ivanovic M et al (2009)[110] 17.8 
4. Theoharis CG et a[111] 3.0 
5. VanderLaan M et al[112] 10.9 
6. Marchevsky AM et al(2010) [113] 9.8 
7. Jo VY et al (2010) [114] 3.4 
8. Renshaw AA et al (2010)[115] 7.7 
9. Bhagat VM et al (2014)[18] 0 
10. Present study 0.3 
 
The TABLE-16 shows the AUS percentages in present study and in 
different series, the AUS percentage in present study was very less compared 
to other studies except in the studies done by Bhagat VM et al (2014) 
reported nil case under this category, the highest percentage of cases under 
 
 
99 
 
this category was reported in the studies of Nayar R in Ivanovic M et al 
(2009). 
 
CATEGORY IV: FOLLICULAR NEOPLASM / SUSPICIOUS FOR 
FOLLICULAR NEOPLASM:  
The main aim of this category is to potentially identify all the 
follicular carcinomas and and help in the proper management of these 
lesions and refer them for a surgical lobectomy. The cytomorphological 
features do not permit a clear cut distinction of a follicular adenoma from a 
follicular carcinoma, they are reported as follicular neoplasm or suspicious 
for follicular neoplasm, thus leading to a definitive management to the 
patients like usually lobectomy is carried out. The majority of the lesions 
reported under this category turn out to be a follicular adenoma or 
adenomatoid nodules of multinodular goiter, both of them are common and it 
usually outnumbers the lesions such as follicular carcinoma. 
In the present study 12 cases (4%) were studied under this category. 
The other studies done by various authors showed various percentages under 
this category which are mentioned in the TABLE-17.[99] 
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TABLE - 17: Percentage of thyroid lesions in FN/SFN category in 
different series. 
S.NO      SERIES FN/SFN (%) 
1. Faquin WC in Krane J F et al (2011)[108] 2.0 
2. Kim SK et al (2011) [109] 1.2 
3. Nayar R in Ivanovic et al (2009) [110] 5.9 
4. Theoharis CG et al (2009)[111] 5.5 
5. VanderLaan PA et al (2011) [112]  4.2 
6. Marchevsky AM (2010) et al[113] 1.5 
7. Jo V Y et al (2010)[114] 9.7 
8. Renshaw AA et al (2010) [115] 8.6 
9. Present study 4.0 
 
The TABLE-17 shows the percentage of Follicular neoplasm / Suspicious 
for follicular neoplasm cases in present study and in different series. Our 
study showed 4% of cases diagnosed under this category which were similar 
with the studies done by VanderLaan PA et al (2011). The highest number of 
cases were reported in the series of Nayar R in Ivanovic et al (2009). The 
other series showed less number of cases diagnosed under this category 
compared to our study. Kim SK et al (2011) series reported least number of 
cases under this category.  
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CATEGORY V : SUSPICIOUS FOR MALIGNANCY :  
This category includes the lesions that in which the nuclear and 
architectural features are very subtle to classify them as malignant, so they 
are best classified as suspicious for malignancy, the lesions like follicular 
variant of papillary carcinoma the nuclear features are so subtle sometimes 
so that it becomes difficult to distinguish it from the benign follicular nodule. 
If only few characteristic features of papillary thyroid carcinoma are present, 
in a very sparsely cellular sample, a definite diagnosis of malignancy is not 
possible and such lesions are best classified under this category as suspicious 
for malignancy. 
In the present study 2 cases were present under this category showing 
a percentage of 0.7%, the other studies conducted by various authors 
Showed various distributions of lesions under this category which are 
mentioned in (TABLE -18 ). 
TABLE- 18: Percentage of thyroid lesions in SFM category in different 
series. 
S.NO SERIES SFM (%) 
1. Faquin WC in Krane J F et al (2011)[108] 3.2 
2. Kim SK et al (2011) [109] 6.2 
3. Nayar R in Ivanovic et al (2009) [110]  1.9 
4. Theoharis CG et al (2009)[111] 1.3 
5. VanderLaan PA et al (2011) [112] 4.5 
6. Marchevsky AM (2010) et al[113] 2.3 
7. Jo V Y et al (2010)[114] 2.3 
8. Renshaw AA et al (2010)[115] 1.8 
9. Present study 0.7 
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The TABLE-18 shows the percentage of cases in the suspicious for 
malignancy category in present study and in different series. In this study the 
number of cases reported under this category were less compared to other 
studies. The studies done by Kim SK et al (2011) showed the highest number 
of cases under this category followed by the series of VanderLaan PA et al 
(2011) . Other series reportedly had average number of cases diagnosed 
under this category. 
CATEGORY VI : MALIGNANT  
This category is used when the cytological and nuclear features are 
indicative of a clear cut malignancy. Approximately 6-7% of thyroid FNAs 
have conclusive evidence of malignancy. And most of the malignant lesions 
usually are papillary carcinoma in type. Malignant lesions are usually treated 
by total thyroidectomy. 
In the present study 8 cases(2.7%) out of 300 patients were diagnosed 
as malignant all of them showed features of papillary carcinoma. The studies 
done Bhagat V M et al (2014) reported 11 cases (6.88%) of neoplastic 
lesions. In the series of Mufti ST et al the malignant lesions included 8 cases 
(3.6%). The malignant lesions studied by different authors under Bethesda 
system shows the percentage of malignant lesions in thyroid which are 
mentioned in [TABLE – 19 ].  
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TABLE – 19 : Percentage of thyroid lesions in malignant category 
according to Bethesda classification in different series. 
S.NO SERIES MALIGNANT (%) 
1. Faquin WC in Krane J F et al (2011)[108] 3.9 
2. Kim SK et al (2011) [109] 16.2 
3. Nayar R in Ivanovic et al (2009) [110] 4.9 
4. Theoharis CG et al (2009)[111] 5.2 
5. VanderLaan PA et al (2011) [112] 5.2 
6. Marchevsky AM (2010) et al[113] 2.0 
7. Jo V Y et al (2010)[114] 7.0 
8. Renshaw AA et al (2010) [115] 4.2 
9. Present study 2.7 
The TABLE- 19 shows the percentage of cases diagnosed under the category 
of malignant lesions according to Bethesda in present study and in different 
series. Kim SK et al (2011) series had the highest number of cases diagnosed 
under this category followed by the series of Jo V Y et al (2010). The 
percentage of cases in our study correlated with the series done by 
Marchevsky AM (2010) et al. Other series showed a slight higher percentage 
of cases under this category compared to our present study. 
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COMPARISON OF FNA DIAGNOSES BETWEEN THE PRESENT 
STUDY AND THE PUBLISHED VALUES IN OTHER STUDIES, 
EXPRESSED AS A PERCENTAGE OF ALL FNAs[100] 
TABLE- 20 : Percentage of thyroid lesions according to Bethesda in 
present study and various other studies. 
FNA 
Diagnoses 
Present 
study 
N=300 
Williams et 
al 2006 [116] 
N=1491 
Yang et 
al., 
2007 [117] 
N = 4703 
Jo et al., 
2010 [118] 
N=3080 
Wu et 
al.2011 
[119] 
N=1382 
ND 1% 28.9% 10.4% 18.6% 20.1% 
BENIGN 91.3% 45.7% 64.6% 59.0% 39.0% 
AUS/FLUS 0.3% 18.8% 3.2% 3.4% 27.2% 
FN/SFN 4% 4.4% 11.6% 9.7% 8.4% 
SFM 0.7% 1.3% 2.6% 2.3% 2.6% 
MALIGNANT 2.7% 0.9% 7.6% 7.0% 2.7% 
       
The TABLE -20 shows the comparison of thyroid lesions classified 
under Bethesda in present study and in different series. The benign lesions 
comprised of highest number of cases in present study compared to all other 
studies, other studies also showed highest number of cases in benign 
category compared to other categories. In the present study AUS category 
showed the least number of cases compared to other studies. The cases in the 
SFN/FN category were similar with the studies of William et al as shown in 
 
 
105 
 
[TABLE – 20], other studies showed higher number of cases. In the present 
study the cases in the SFM category were also comparable with Williams et 
al [100], other studies showed higher number of cases. The cases in the 
malignant category were similar as that studied by Wu et al, whereas 
Wiliams et al reported a least number of cases under this category,other 
studies showed a slight higher percentage. 
     These data demonstrate that the Betheseda system is excellent for 
reporting thyroid FNAs. Each diagnostic category conveys specific risks of 
malignancy and offers appropirate guidance for patient’s management.              
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SUMMARY 
A prospective study of fine needle aspiration cytology of nodular and 
diffuse lesions of thyroid was carried out and the cytomorpholgy of these 
lesions were studied and reported with emphasis on Bethesda system of 
reporting, during the period from January 2013 to June 2014 in the 
Cytopathology laboratory of the Department of Pathology, Tirunelveli 
Medical College, Tirunelveli  
The findings in the present study can be summarised as follows: 
 FNAC was performed on 300 cases for cytological evaluation of 
the thyroid lesions and classifying them in Bethesda. 
 Out of the total aspirations 3 cases were unsatisfactory aspirations. 
Age of the patients ranged from 9 – 85 years of age. The youngest 
patient was a 9 year old female and the oldest was an 85 year old 
female. 
 Females formed the predominant group comprising of 283 cases 
(94.3%) out of the total 300 cases. 
 Majority of the patients in the present study were in the third to 
fourth decade of life. 
 Of the total 300 cases, the majority of the cases were benign 
(91.3%) 
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 Among the malignancies, all of them were papillary 
carcinomas(100%) 
 The cytomorpholgical profile of nodular and diffuse thyroid lesions 
were classified by Bethesda as non diagnostic, benign, atypia of 
undetermined significance/ follicular lesion of undetermined 
significance, follicular neoplasm / suspicious for follicular 
neoplasm, suspicious for malignancy and malignant categories. 
  Out of the total 300 cases highest number of cases occurred in 
category II benign comprising of 274 cases (91.3% ), Non –
diagnostic category comprising of 3 cases (1%), under the category 
of Atypia of undetermined significance / Follicular lesion of 
undetermined 1 case (0.3%) was reported, and under the category 
of Suspicious of malignancy 2 cases(0.7%) were reported. 
 Under the category of malignant lesions 8 cases (2.7%) were 
reported and all of them were papillary carcinoma of thyroid.  
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CONCLUSION 
 FNAC is simpler, safer,quicker and more informative compared to 
other sophisticated investigations in the diagnosis of thyroid lesions. 
 When there is a marked cellularity of the smear it is an inherent 
problem in thyroid FNAC. Increased cellularity of the smear and loss 
of cohesion may be present in hyperplastic/adenomatous goiter and 
follicular neoplasm which causes difficulty in differentiating them. 
This can be solved by using the Bethesda System of Reporting thyroid 
lesions. 
 The Bethesda system for reporting thyroid cytology plays an essential 
role in establishing the uniform communications between the 
managing medical personnel. 
 The Bethesda system of reporting thyroid cytology is a vital guide in 
the accurate management of thyroid lesions. 
 Thus we conclude that by using the Bethesda reporting system in 
thyroid cytology it helps in the prognosis, management and in the 
patient’s outcome and also minimizes the unnecessary surgical 
procedures for thyroid swellings. 
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APPENDIX - I 
INFORMED CONSENT FORM 
Study Title :  Cytomorphological Evaluation Of Nodular And Diffuse Thyromegaly With 
Emphasis On Bethesda System Of Reporting – A  Prospective Study. 
StudyNumber__________________________________________________ 
Subject's Full Name _____________________________________________ 
Date of Birth/Age_______________________________________________ 
Address 
_____________________________________________________________
_____________________________________________________________ 
 
1. I confirm that I have read and understood the information sheet dated 
for the above study and have had the opportunity to ask questions. or I 
have been explained the nature of the study by the Investigator and 
had the opportunity to ask questions 
2. I understand that my participation in the study is voluntary and that I 
am free to withdraw at anytime, without giving any reason and 
without my medical care or legal rights being affected. 
3. I understand that the sponsor of the clinical trial/project, others 
working on the Sponsor's behalf,the Ethics Committee and the 
regulatory authorities will not need my permission to look at my 
health records both in respect of the current study and any further 
research that may be conducted in relation to it, even if I withdraw 
from the trial. However, I understand that my Identity will not be 
revealed in any information released to third parties or published. 
4. I agree not to restrict the use of any data or results that arise from this 
study provided such a use isonly for scientific purpose(s) 
5. I agree to take part in the above study 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative: ____________________ 
Signatory's Name ______________________________________  
Date __________________________ 
Signature of the Investigator _____________________________ 
Date __________________________ 
Study Investigator's Name ________________________________ 
Signature of the Witness ________________________________  
Date __________________________ 
Name of the Witness 
  
NehahspfSf;F mwptpg;G kw;Wk; xg;Gjy; gbtk; 
kUj;Jt Ma;tpy; gq;Nfw;gjw;F 
Ma;T nra;ag;gLk; jiyg;G       : Kbr;RU kw;Wk; gutyhd ijuha;L Rug;gpapd;   
capuZ mikg;gpay; kjpg;gPl;il ngj];lh 
Kiwapd; %yk; typAWj;Jk; mwpf;if. Xh; 
tUq;fhy Ma;T. 
gq;F ngWgthpd; ngah;  :  
gq;F ngWgthpd; taJ : 
  gq;F ngWgth; ,jid 
Fwpf;fTk; 
1. ehd; NkNy Fwpg;gpl;Ls;s kUj;J Ma;tpd; 
tptuq;fis ehd; gbj;J Ghpe;J nfhz;Nld;. 
vd;Dila re;Njfq;fis Nfl;fTk;> mjw;fhd jFe;j 
tpsf;fq;fis ngwTk; tha;g;gspf;fg;gl;Ls;sJ vd 
mwpe;J nfhz;Nld;. 
 
2. ehd; ,t;tha;tpy; jd;dpr;irahf jhd; gq;Nfw;fpNwd;. 
ve;j fhuzj;jpdhNyh ve;j fl;lj;jpYk;> ve;j rl;l 
rpf;fYk; cl;glhky; ehd; ,t;tha;tpy; ,Ue;J tpyfp 
nfhs;syhk; vd;Wk; mwpe;J nfhz;Nld;. 
 
3. ,e;j Ma;T rk;ge;jkhfNth> ,ijr; rhh;e;J NkYk; 
Ma;T Nkw;nfhs;Sk; NghJk; ,e;j Ma;tpy; gq;F 
ngWk; kUj;Jth; vd;Dila kUj;Jt mwpf;ifia 
ghh;g;gjw;F nfhs;fpNwd;. ehd; Ma;tpy; ,Ue;J 
tpyfpf; nfhz;lhYk; ,J nghUe;Jk; vd mwpfpNwd;. 
 
4. ,e;j Ma;tpd; %yk; fpilf;Fk; jftiyNah> 
KbitNah gad;gLj;jpf; nfhs;s kWf;f khl;Nld;. 
 
5. ,e;j Ma;tpy; gq;F nfhs;s xg;Gf; nfhs;fpNwd;. 
vdf;F nfhLf;fg;gl;l mwpTiufspd; gb ele;J 
nfhs;tJld; Ma;it Nkw;nfhs;Sk; kUe;J mzpf;F 
cz;ikAld; ,Ug;Ngd; vd cWjpaspf;fpNwd;. vd; 
cly; eyk; ghjpf;fg;gl;lhNyh> my;yJ vjph;ghuhf 
tof;fj;jpw;F khwhd Neha;Fwp njd;gl;lhNyh clNd 
,ij kUj;Jt mzpaplk; njhptpg;Ngd; vd cWjp 
mspf;fpNwd;. 
 
 
gq;Nfw;gthpd; ifnahg;gk;/ ____________________,lk; __________ Njjp _____________ 
gq;Nfw;gthpd; ngah; kw;Wk; tpyhrk;  
Ma;thshpd; ifnahg;gk;/ _____________________,lk; __________ Njjp _____________ 
ikak; ____________________ 
fy;tpawpT ,y;yhjth;f;F (ifNuif itj;jth;fSf;F),J mtrpak; Njit 
rhl;rpapd; ifnahg;gk;/ _______________________,lk; __________ Njjp _____________ 
 
ngah; kw;Wk; tpyhrk; ___________________________________________________________ 
APPENDIX - II 
       PROFORMA FOR FINE NEEDLE ASPIRATION CYTOLOGY 
CASE NUMBER : 
NAME :                              
AGE  :         SEX : Male / Female 
HOSPITAL IP/OP NO : 
ADDRESS OF THE PATIENT : 
CONTACT PHONE NO : 
CLINICAL DETAILS : 
DIAGNOSIS : 
INVESTIGATIONS : 
TFT : 
OTHERS : 
PREVIOUS FNAC REPORT : 
FNAC : 
 CYTOLOGY NO   : 
 MACROSCOPIC APPEARANCE: 
         MICROSCOPY : 
         CELLULARITY : 
         CELL TYPE : 
         OTHER CELLS : 
         BACKGROUND : 
 DIAGNOSIS : 
APPENDIX - III 
PROFORMA   FOR   MASTER CHART 
A – PATIENT PROFILE 
A1 CASE NO:  
A2 IP/OP NO:  
A3 FNAC NO:  
A4 AGE 0-9 10-19 20-29 30-39 40-49 50-59 60-69 >70 
1 2 3 4 5 6 7 8 
A5 GENDER MALE FEMALE 
1 2 
 
B – HISTORY 
Presenting complaints 
B1 Swelling 
Neck 
Midline Lateral 
1 2 
B2 Duration of         
swelling 
< 6months 6 – 1 yr 1 – 10  
yrs 
 10 yrs 
1 2 3 4 
B3 Rate of 
growth 
Gradual Sudden 
1 2 
 
 
Pressure effects 
B5 Dyspnoea Present Absent 
1 2 
B6 Dysphagia Present Absent 
1 2 
B7 Hoarseness Present Absent 
1 2 
B8 Pain Present Absent 
1 2 
 
C. GENERAL EXAMINATION 
C1 Pulse Bradycardia Tachycardia Normal 
1 2 3 
C2 Skin Dry Moist Normal 
1 2 3 
 
D . LOCAL EXAMINATION 
D1 Nodule No Single Multiple 
1 2 
D2 Size < 1cm >1cm 
1 2 
D3 Nature of the swelling Nodular Diffuse 
1 2 
D4 Consistency of the 
swelling 
Soft Cystic Firm Hard 
1 2 3 4 
D5 Moves with deglutition Present Absent 
1 2 
 
E  : FNAC FINDINGS 
E1 Nature of aspirate Brown Haemorrhage 
1 2 
E2 Type of smear Direct Centrifuge 
1 2 
E3 Cellularity Sparse Moderate Marked 
1 2 3 
E4 Background Colloid Haemorrhage Inflammatory 
1 2 3 
E5 Distribution of cells Clumps Sheets Follicles Papillary 
1 2 3 4 
E6 Lymphocytes Present Absent 
1 2 
E7 Hurthle cells Present Absent 
1 2 
 
 F : Epithelial cell characteristics 
F1 Size Normal Increased 
1 2 
F2 Shape Round Oval Polygonal Spindle Plasmacytoid 
1 2 3 4 5 
F3 Uniformity Uniform Pleomorphic 
1 2 
Cytoplasm 
F4 Amount Abundant Moderate Scanty 
1 2 3 
F5 Appearance Eosinophilic Basophilic Vacuolated 
1 2 3 
Nucleus 
F6 Shape Round Oval 
1 2 
F7 Ground glass Present Absent 
  
F8 Hyperchromatism Present Absent 
1 2 
F9 Nucleolus Present Absent 
1 2 
F10 Nuclear groove Present Absent 
1 2 
F11 Intranuclear inclusion Present Absent 
1 2 
F12 Salt and pepper 
chromatin 
Present Absent 
1 2 
F13 Multinucleation Present Absent 
1 2 
F14 
 
NC ratio Normal Increased 
1 2 
 
CONVENTIONAL CYTOLOGIC DIAGNOSIS 
G1 Benign Colloid Nodule 1 
  Nodular Goitre 2 
  Adenomatous goitre 3 
  Hashimoto’s thyroiditis 4 
  Follicular Neoplasm 5 
  Granulomatous thyroiditis 6 
  Cystic lesion 7 
  FN/ DN of nodular goitre 8 
 
G2 Malignant Papillary carcinoma 1 
  Follicular carcinoma 2 
  Medullary carcinoma 3 
  Anaplastic 4 
  Metastatic 5 
H . CYTOLOGICAL DIAGNOSIS BY BETHESDA SYSTEM 
H1 Non-diagnostic/ 
Unsatisfactory 
Cyst fluid only 1 
Virtually acellular smear 2 
Others (Obscuringblood / drying arifact) 3 
H2 Benign Consistent with benign follicular nodule 
(Adenomatoid nodule , Colloid nodule) 
1 
Consistent with lymphocytic (Hashimoto) 
Thyroiditis in proper clinical context 
2 
Consistent with granulomatous (subacute 
thyroiditis) 
3 
Other 4 
H3    Atypia of 
undetermined 
significance or 
follicular lesion of 
undetermined 
significance 
 1 
H4 FN/SFN   1 
H5  Suspiciousfor 
malignancy 
Suspiciuos for papillary carcinoma 1 
Suspicious for medullary carcinoma 2 
Suspicious for metastatic carcinoma 3 
Suspicious for lymphoma 4 
Other 5 
H6 Malignant Papillary thyroid carcinoma 1 
Poorly differentiated carcinoma 2 
Medullary thyroid carcinoma 3 
Undifferentiated (anaplastic) carcinoma 4 
Squamous cell carcinoma 5 
Carcinoma with mixed features 6 
Metastatic carcinoma 7 
Non – Hodgkin  lymphoma 8 
Others 9 
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